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Overview of
workbook series
This workbook is part of a series
intended to educate programme
planners, managers, staff and other
decision-makers about the evalua-
tion of services and systems for the
treatment of psychoactive substance
use disorders. The objective of this
series is to enhance their capacity
for carrying out evaluation activities.
The broader goal of the workbooks
is to enhance treatment efficiency
and cost-effectiveness using the in-
formation that comes from these
evaluation activities.
This workbook (Workbook 1) de-
scribes step-by-step methods for
planning evaluations. These steps
span from deciding who will be in-
volved in the evaluation, to defining
your research questions and deter-
mining your data collection methods.
Introductory Workbook
Framework Workbook
Foundation Workbooks
Workbook 1: Planning Evaluations
Workbook 2: Implementing Evaluations
Specialised Workbooks
Workbook 3: Needs Assessment Evaluations
Workbook 4: Process Evaluations
Workbook 5: Cost Evaluations
Workbook 6: Client Satisfaction Evaluations
Workbook 7: Outcome Evaluations
Workbook 8: Economic Evaluations
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Introduction
How does one ensure that resources
for evaluation are not wasted and that
the results are useful? The answer is to
develop a detailed plan before
proceeding with an evaluation.
In most countries, resources avail-
able for the treatment of PSU dis-
orders are scarce. Competition for
these resources has increased the
need for the evaluation of treatment
programmes. Despite the critical
need for evaluation, the evaluation
process itself takes time and re-
sources. It is important, therefore,
that resources available for evalu-
ation are used efficiently, and that
results are useful for making deci-
sions about programmes or treat-
ment systems.
How does one ensure that resources
for evaluation are not wasted and
that the results are useful? The an-
swer is to develop a detailed plan
before proceeding with an evalua-
tion. Developing a plan involves
discussions with various people
who have interest in the
programme. In these discussions,
specific questions are identified
that will be answered by informa-
tion collected in the evaluation, and
be of value to one or more groups
in decision-making processes. This
workbook discusses the steps in-
volved in planning for evaluation
and offers practical strategies to
help guide this process. The more
carefully you plan at this stage, the
more benefits you will reap from
your evaluation efforts.
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As described in the framework manual,
you need to accomplish eight steps
during this evaluation-planning phase:
1. Decide who will be involved in the evaluation.
2. Assess your evaluation resources.
3. Describe your programme for evaluation.
4. Identify and prioritise the evaluation needs.
5. Define your evaluation questions.
6. Determine your evaluation measures.
7. Determine your evaluation design.
8. Ensure that your evaluation resources are sufficient. If not,
return to Step 4.
Each of these steps is presented in the fol-
lowing pages. The discussion of these
steps will include a fictional example of a
group of people planning an evaluating of
their opiate detoxification programme and
some exercises for you to follow. The fic-
tional example will give you an idea about
the key steps undertaken by a group of
people evaluating their opiate detoxification
programme. The example will show you how
the presented steps can be transferred into
action. Keep in mind that the example will
show you how the steps can be accom-
plished in an ideal way. The exercises will
help you to learn and apply the material to
your own situation.
The eight steps of
planning evaluations
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   If you are conducting a...        Then you should review...
Needs Assessment Evaluation Workbook 3
Process Evaluation Workbook 4
Cost Evaluation Workbook 5
Client Satisfaction Evaluation Workbook 6
Outcome Evaluation Workbook 7
Economic Evaluation Workbook 8
Use the foundation and specialised
workbooks together, to help you make
the most of the information that is
presented.
Workbooks 1 and 2 provide a solid founda-
tion of general information about conducting
evaluations, whereas the specialised work-
books (Workbooks 3 through 8) present de-
tailed information for different types of evalu-
ation. If you already know what type of
evaluation you are going to conduct, you
should consult the workbook that is appli-
cable. Use the foundation and specialised
workbooks together, to help you make the
most of the information that is presented. If
you do not know what type of evaluation you
are going to conduct, wait until you have
developed your evaluation questions (Step
5) to consult a specialised workbook.
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Step 1
Decide who will be
involved in the evaluation
An important first step is to identify and meet
your evaluation planning “partners,” if you
have not already done so. Depending on your
situation, your partners may include:
• therapists or clinicians
• programme administrators or managers
• researchers
• government representatives
• patients interested in participating
All partners should be closely involved in the
evaluation planning. Each partner has unique
experiences and perspectives that can con-
tribute to the group’s knowledge base and
strengthen the overall evaluation. Other ben-
efits include:
• bringing multiple perspectives to the
planning
• strengthening everyone’s commitment
to use the findings
• adding credibility to the process
Into action
Our fictional example concerns a group of
people who plan and implement an evalu-
ation in their 25-bedded heroin detoxifi-
cation service. This in-patient detoxifica-
tion programme is designed for clients with
opiate dependence. Clients stay at the ser-
vice for 21 days. The needs of each indi-
vidual are met through individual and group
therapy during a three week structured
programme that includes relapse preven-
tion, stress management, health and AIDS
education programmes. The partners who
are involved in planning and implement-
ing the evaluation are:
Sue R.: Psychiatrist and sees patients regu-
larly, she knows what kind of problems ex-
perience clients during their detoxification
and has a good sense of what kinds of
evaluation will/will not work in the
programme setting, get along well with oth-
ers.
Adam S.: Scientific researcher: Knows
about statistics, computers and evaluation,
can do data analysis, can provide about
the “scientific” quality of our evaluation
plan, good sense of humour.
Chris C.: Drug worker: Sees clients and
does pre-treatment assessments, indi-
vidual counselling and group session;
can co-ordinate and conduct interviews
with clients.
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Maria M.: Programme secretary: Very
organised. She is responsible for entering
intake and termination forms of clients into
the central database.
Other people who will get involved in their
evaluation are representatives of funding bod-
ies, other drug workers and clients attending
the 21-day treatment service.
Its your turn (1 A)
1 First, list the names of your partners who
are involved in your evaluation planning
project. Then, list the unique talents that
each person brings to the group.
2 Discuss how you can take advantage of
each other’s talents to maximise the
evaluation planning process.
3 Working individually, list three hopes
about the evaluation project, and then
list three fears. When everyone has fin-
ished, share and discuss the lists. Make
plans for how to attain your hopes and
overcome your fears.
In any given situation, many other people
can be involved potentially in evaluation.
These might include:
• other therapists or clinicians
• supervisors or programme managers
• senior programme administrators or
Board members
• other researchers
• representatives of government or other
funding bodies
You and your partners might want to de-
velop a larger evaluation committee that
has representation from these groups, in-
cluding patients/clients. Another idea is to
collect information from them during this
planning phase to identify the kinds of ques-
tions they would like to have answered, and
the decisions they anticipate having to make.
Its your turn (1 B)
1 List ALL the groups of people involved in
your treatment programme, or network of
programmes. The list will be unique to your
situation, but may include:
− patients/clients
− family members
− senior managers
− Board members
− staff (therapists/clinicians)
− researchers
− funder(s)
− representatives of other programmes or
service systems in your community
− people living in your community
2 Decide how to best involve representa-
tives from each of the different groups.
Very likely, some groups will be in-
volved closely throughout treatment
evaluation, whereas others may partici-
pate only in a limited way. You might
want to develop an evaluation commit-
tee that has representation from these
groups, including patients/clients. Or,
you could collect information from
them during this planning phase to iden-
tify the kinds of questions they would
like to have answered, and the deci-
sions they anticipate having to make.
Write down how you will involve each
of these groups.
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Step 2
ation realistically, and then choose a project
that is practical with the resources that you
can devote to it.
In this workbook’s Timmins Detoxifica-
tion Service evaluation case example,
planners evaluated their resources and
decided subsequently to hire a programme
evaluation consultant. While this type of
added expense may not be possible for all
evaluations, it is noteworthy that it was
helpful in this evaluation.
Assess your
evaluation resources
Evaluation requires resources. Specifically,
evaluation requires financial/material re-
sources, expertise resources, and time re-
sources. It is important for you to evaluate
your level of “evaluation readiness” along
each of these dimensions, and then to bal-
ance your resources with the type of project
that you undertake.
Remember that high quality evaluations
CAN be conducted with very few re-
sources. The key is to evaluate your situ-
Into action
The fictional evaluation team discussed their
resources along the following dimensions:
Financial/Material Resources
Sue R. informs the others, that no internal
funding can be devoted to the evaluation
project, however the local health purchaser
agreed to fund their project with 300,000
US Dollars. This money enables the ser-
vice to employ one person (Adam S.) part-
time for the evaluation project during the
planing phase of the evaluation and after
the data collection, when the data is to be
analysed.
One single office, provided with a computer
will be used for data storage, entry and analy-
sis. Other facilities, such as photocopier and
cabinet files are available in the office of the
programme secretary.
Expertise Resources
Sue R. attended a one-day workshop about
evaluation and will communicate her
knowledge to other members of the team.
Chris C. has been involved in other re-
search studies. He is familiar with data
collection, e.g. conducting standardised
interviews. Adam S. will assist in planing
and analysing the data for the evaluation.
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As part of her duties, Maria M. has been
entering intake and termination forms for
all clients for the last two years. She is
familiar with data entry and data entry
software.
Time Resources
Existing staff agreed to assist with the data
collection. They will have to devote an ad-
ditional 2 hours per client for the collec-
tion of baseline data and follow up. Adam
S. will work part time (20 hours/per
week) for approximately one month and
approximately 3 month after the data col-
lection. Sue R. will devote an additional 3
hours per week for the project. Her time
for the project will depend on the demands
of the evaluation. Maria M. will not have
to devote more time for the project, be-
cause entry of records are already part of
her duties at the service.
Its your turn
Evaluate your resources along the following
dimensions:
Financial/material resources
1 Is there internal funding that can be de-
voted to this evaluation project? If yes,
what amount?
2 Are there external funding agencies that
can provide funding for this project? If
yes, what amount?
3 Can you afford to hire evaluation staff, or
will evaluation be conducted by existing
staff members (e.g., treatment agency
staff)?
4 Is there a computer (and software)
available for data entry and data
analysis? (Note: computers are not nec-
essary for all evaluations)
5 Is there a photocopier available for copy-
ing survey materials, etc.?
Expertise resources
1 Has anyone involved on the project con-
ducted treatment evaluations before? If
yes, in what capacity?
2 Has anyone involved on the project
worked on a computer before, specifi-
cally doing data entry or data analysis?
3 Do you have access to expert “consult-
ants,” who can provide advice on con-
ducting the evaluation and/or analysing
the data?
Time resources
1 How much time will each person have
available to devote to the evaluation
project each week?
2 If you will rely on existing staff to collect
data and/or analyse data, how much time
will they have to devote to this each
week?
Your answers to these questions should
help determine the type of evaluation to
undertake. For example, if you do not have
access to or expertise with computers, you
probably will want to collect data that can
be tallied and evaluated by hand. Later,
you will have a chance to make sure that
the project you have chosen fits well with
your resources. But for now, it is suffi-
cient just to know the answers to these
questions.
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Step 3
Into action
Describe your
programme for
evaluation
Every health or social service can be described according to the following structure:
• resources that are organised for a common purpose
• activities that are planned and undertaken
• immediate outcomes that are to be achieved
• longer term outcomes that are intended
• other positive or negative consequences or side-effects
In our fictional example, the resources de-
voted to operating a detoxification unit in-
clude a 25-bed facility, with sixteen staff
and an annual budget of $480,000 (U.S.).
Programme activities include withdrawal
management, medical screening, referral,
individual and group therapy, health and
AIDS education and general support to help
to stabilise the person, physically and emo-
tionally. The immediate outcomes are
safe withdrawal from opiates and in-
creased motivation for seeking further treat-
ment. Longer-term outcomes are in-
creased participation in treatment, decreased
PSU and high-risk behaviour, improved
health and social well being, decreased use
of hospital inpatient facilities and reduction
in hospital costs. Reduced criminality rates
and unemployment rates may be a positive,
unanticipated side effect of introducing an
opiate detoxification unit. The information
about the treatment unit can be represented
graphically in the following manner:
Programme Resources
• $ 480,000 annually
• 16 staff members
Programme Activities
• withdrawal management
• individual and group therapy
• motivational interviewing
• referral to long term treatment
• health and AIDS education
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Immediate Programme Outcomes
• safe withdrawal
• increase knowledge about AIDS
• increased motivation for further treatment
Longer -Term Programme Outcomes
• increased participation in treatment
• decreased use of illicit substances
• decrease in high-risk behaviour
• increased health
(Side Effects)
It is useful to outline your own programme in
this manner, so that you can see the underlying
logic or rationale of your programme, or the
links between your programme activities with
shorter and longer-term outcomes. Develop-
ing a “programme logic model” like this will help
you in planning your evaluation. Why? In ad-
dition to challenging you to defend, and per-
haps refine the logical basis underlying your
programme, the process of stating your ob-
jectives will make you aware of the need for
clarity and specificity in these objectives. The
clearer you make your objectives, the easier
the next phase of evaluation planning will be
when you decide how to measure your suc-
cess in achieving those objectives.
In addition, experience has shown that hav-
ing an agreed upon logic model among key
partners serves as a strong foundation for
planning and prioritising your evaluation
activities. It is one of the most concrete
steps you can take towards a successful
evaluation plan.
This workbook’s case report of the
Timmins Detoxification evaluation de-
scribes how all partners were involved in
creating their programme logic model.
Their joint effort helped identify specific
evaluation questions.
Its your turn (3 A)
Using the example outlined earlier as a guide,
describe your own treatment programme. To
help identify your programme activities, ask
yourself, “what are the main things we do to
accomplish our goals?”
• Programme Resources
• Programme Activities
• Immediate Programme Outcomes
• Longer - Term Programme Outcomes
• (Side Effects)
Sometimes, it is helpful to describe your
programme further by distinguishing be-
tween process objectives and outcome
objectives.
• Process objectives: planned activities
or services
• Outcome objectives: the expected
changes that will occur
Ô
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Into action
Example of outcome objective
• to help the client to withdraw from
opiates
• to increase health
• to reduce PSU
• to increase life-skill and knowledge
about AIDS and consequences of PSU
• to decrease high risk behaviour
The fictional heroin detoxification programme has the following examples of process and
outcome objectives:
Process objectives
• to administer standardised assessment
instruments
• to provide individual and group therapy
• to assist the clients in entering long-
term treatment
• to provide information on consequences
of PSU and AIDS
You can usually distinguish process and outcome objectives by the verb contained in the
sentence. Process objectives use verbs that reflect activities while outcome objectives use
verbs that reflect changing something. Examples of process and outcome objectives (used in
an overall programme logic model) are shown bellow.
Inpatient opiate detoxification service - programme logic model
Intake &
Assessment
to gather basic
information on clients
to administer standardised
assessment instruments
to develop a withdrawal
management
to provide individual counselling
to provide group counselling
(e.g. relapse prevention)
to implement clients’ treatment
plans
to provide crisis intervention
to provide safe withdrawal
from opiates
to assist clients in finding long
term treatment
to teach basic life skills
to provide information on
consequences of substance
use
to teach AIDS education
to increase clients motivation for
further treatment
to increase health
to withdraw clients from opiates
Main components
to stabilise clients and their
situation
to improve life skills
to refer clients to long term
treatment
to improve the general well-being of the client
to reduce high-risk behaviour
to reduce PSUto increase clients participation
in treatment
Long-term outcomes
Counselling Education Stabilisation
Short-term outcomes
to increase clients knowledge
of AIDS and consequences
of substance use
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Its your turn (3 B)
For each of the programme activities that you
listed in the last exercise, now list the various
process objectives that go with that compo-
nent. There is usually more than one process
objective for each activity.
Do the same with your outcome objectives.
Some may be more attainable in the short-
term, while others are long-term and only
occur after other preceding objectives
have been met. There should be an order-
ing or rationale linking the outcome objec-
tives. Draw these logical connections.
Last, draw a line from each set of pro-
cess objectives to the short-term out-
comes expected as a result of success-
fully implementing these activities and
services. Here you are drawing the causal
linkages that not only show what goes
on in your programme, but also why it
should work.
Main
components
(e.g. assessment,
detoxification, follow-up)
Implementation
objectives
(e.g. to determine
correct diagnosis, to
provide substance
resistance skills, to
monitor health status.)
Planned
short-term
outcome
objectives
(e.g., to increase
motivation for
further treatment, to
decrease the
likelihood of
relapse).
Planned
long-term
outcome
objectives
(e.g. to decrease
substance abuse, to
improve quality of life)
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Step 4
Identify and
prioritise
evaluation needs
Different groups will have different ideas
about what to evaluate. For example, man-
agers or administrators may be most in-
terested in costs and office efficiency,
while clinicians may be interested in the
benefits of a particular new treatment. It is
important for you to understand the views
and priorities of your partners, and all key
groups, then to come to a decision about
the overall needs for evaluation.
Into action
The evaluation team of the opiate treatment
unit discussed their ideas of what is impor-
tant to evaluate within their programme and
why. They agreed upon that they are inter-
ested in the effectiveness of their AIDS edu-
cation programme which was incorporated
into the treatment programme a few month
ago. They are further interested if the
programme accomplished what was ex-
pected to accomplish in terms of completion
rates, referrals to long-term treatment, num-
ber of referrals to the service and possible
changes in clients’ characteristics attending
the service. The latter would provide infor-
mation if the service needs to adjust his man-
agement to changes in client characteristics.
Information about completion rates, number
of referrals to the service and from the ser-
vice to long term treatment could provide evi-
dence to the sponsors of the treatment that
the funds are being used as expected.
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Its your turn
1 Working individually, write down your
ideas for what is important to evaluate
within your programme or treatment net-
work, and why. Next, brainstorm a list
of evaluation questions for which you
would like to get feedback.
2 Discuss your ideas with your partners.
Take time to understand each partner’s
perspective. Discuss similarities and
differences in your ideas.
3 Get as much input as you can from other
key people. You can do this with face-
to-face discussions, telephone inter-
views or brief self-completed question-
naires.
− patients/clients
− family members
− senior managers
− Board members
− Staff (therapists/clinicians)
− volunteers
− funder(s)
− representatives of other programmes
or service systems
− people living in the community
These initial exercises will help you to see
the range of possibilities for your evaluation.
They also may help you to see some com-
mon trends in ideas.
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Step 5
At this stage in your evaluation planning, you
have clearly identified your partners in the
evaluation process and involved others in the
planning in a meaningful way. You also have
evaluated your resources, and started to
identify and prioritise your evaluation needs.
Finally, you have defined and assessed the
structure and logic of the programme, or net-
work of programmes, to be evaluated. It is
now necessary to narrow down the precise
questions to be answered.
Questions can be addressed about any
part of the programme structure, logic
or process. The programme logic model
is a useful tool for helping to generate
these questions and narrowing the focus
Define your
evaluation questions
of the evaluation. This section provides a
format for going from your logic model to
this more detailed planning of the evalua-
tion.
It is essential that the expected user(s) of
the evaluation be involved in the process
of identifying evaluation questions. In
working through the completion of the next
exercises, you may end up with more evalu-
ation questions than can be answered with
the time and resources available. If this
happens, it is essential that the user(s) of
the evaluation information be involved in
discussions to narrow the questions to a
meaningful number.
Into action
The following are some examples of possible
evaluation questions generated by the evalu-
ation team at the heroin detoxification ser-
vice.
Questions on client characteristics
• Has the number of referrals increased
from the previous year?
• Has the number of self-discharges de-
crease from the previous year?
• Are the characteristics of clients similar
to the type of clients reflected in the
programme objectives and similar to
the characteristics of clients in the pre-
vious year?
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Questions on clients satisfaction
Its your turn
1 Using the programme logic model that you
created during Step 4 as a guide, write
down possible evaluation questions be-
low. At this stage, write down as many
questions as possible. Ensure that each
partner has an opportunity to contribute
questions.
2 For each question that you generated
above, list advantages and/or disadvan-
tages of studying THIS evaluation ques-
tion. Think about your resources (Step
2) while considering advantages and
disadvantages.
3 Discuss the options with your partners.
As a group, choose the best evaluation
question(s).
4 Discuss your choices with the expected
user(s) of the evaluation results. De-
termine if they agree with your choices.
Change your questions as appropriate.
• Did clients find the types of content in the
programme useful?
• How satisfied were clients who attended
the detoxification?
Questions on programme delivery
• How many hours of counselling were pro-
vided to each client individually and in-
groups?
• What proportion of these hours involved
direct contact with the client compared
to the proportion of hours involving
contact with others about the client?
Questions on outcome
Remember, these are just EXAMPLES of
evaluation questions. Your question(s) may
be different.
The case example of the Timmins Detoxi-
fication service evaluation, located at the
end of this workbook, identified questions
from a variety of domains: service aware-
ness, assessment, crisis intervention, with-
drawal management, follow up care, and
volunteers. In this case, domain repre-
sented a different function of the detoxifi-
cation programme.
• Did attitudes in favour of HIV low-risk
practices improve among clients?
• Did clients awareness and knowledge
about HIV high-risk situations in-
crease?
• Did clients who completed the
programme decrease their PSU?
• Did counselling increase the proportion
of clients who accepted long-term treat-
ment?
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Step 6
Its your turn (6 A)
Choose the best-suited person from your
evaluation planning team to read the fol-
lowing section, A Primer on Measure-
Determine your
research measures
Why should you care about research measures?
What happens if you don’t take research
measurement issues seriously during
programme evaluation? Simply put, any
claims you make about the programme will
always be open to criticism. Someone
could always say: “This sounds nice, but
how do you actually know your programme
accomplishes that?” By using good mea-
sures and data collection techniques, you
can provide a better response to this ques-
tion. For this reason, systematic measure-
ment in programme evaluation is the
best tool you have for convincing people
about what your programme does, how
it functions, what outcomes are achieved
and what has been done to improve it.
This section (Step 6) provides necessary
background information to ensure that you
make good decisions about your research
measures. If you have a researcher on your
evaluation planning team, he/she should re-
view the material in this section, then ex-
plain key concepts to the rest of the group.
Although some of this information may
seem “abstract,” it is important for all part-
ners to have a basic understanding, and
for at least one partner to have a complete
understanding of what is presented. By
doing this, your team will be in a better
position to conduct high quality evalua-
tions.
If you need detailed information or train-
ing on how to gather valid, reliable and
timely data on the prevalence, trends, and
patterns of substance use, qualitative and
quantitative methods for data collection
and analysis, there is a variety of publi-
cations available in substance use epi-
demiology which you may wish to con-
sult. The WHO Programme on Substance
Abuse has also prepared a comprehen-
sive Guide to Drug Abuse Epidemiol-
ogy which is available upon request
(WHO/MSA/PSA/97.14).
ment Concepts, then explain key con-
cepts to the rest of your team.
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A primer on measurement concepts
The next pages present crucial information for you to understand before choosing a
specific measure. So make yourself comfortable and take some time to carefully read
the following information. Throughout this section, you will have the opportunity to test
your knowledge about the information that has been presented, and put it into action
concerning your own evaluation project.
Each of the implementation objectives
in a programme has an output, and
each output has an indicator of ser-
vice delivery and/or characteristics of
those served. Each indicator is a mea-
sure of the outputs that a programme
produces at each stage of the treat-
ment process.
Every programme should have clearly
defined components and implementation
objectives. For each objective, you
should try to come up with an indica-
tor or measure that tells you whether
the objective has been met. By keeping
a systematic record of all the indicators
associated with each objective or out-
come, you are systematically measuring
how well the programme is doing.
1. What are indicators?
Indicator variables are measurable pieces
of information that indicate whether a
programme is achieving an objective. Ear-
lier, you learned about programme logic
models. A logic model outlines the ex-
pected activities and services to be pro-
vided (i.e., process objectives) and the
changes expected as a result of these ac-
tivities and services (i.e., outcome objec-
tives). In your evaluation planning, you
use this logic model to develop the in-
dicators to assess the achievement of the
objective. Each objective of your treat-
ment service or system has correspond-
ing outputs and there are one or more
indicators of these outputs. This relation-
ship is illustrated below.
How does measurement fit into this
situation?
Program
component
Implementation
objective
Outputs
(indicators of service
delivery and characteristics
of those served)
Client assessment
1) Trained
assessment
worker is
available
2) Compre-
hensive
assessment
protocol
completed
3) Treatment
plan prepared
and client
assigned to
treatment
Indicator #1 Indicator #2 Indicator #3
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Claim Confidence
Level
Indicator
“Our PS
awareness
programme is
effective”
Very Low I heard it through the grapevine
“Our PS
awareness
programme is
effective”
“Our PS
awareness
programme is
effective”
Medium 40 out of 50 people in the programme
checked off “effective” or “highly
effective” in a satisfaction questionnaire
completed at the end of the programme.
“Our PS
awareness
programme is
effective”
High Compared to pre-test scores, scores on an
alcohol knowledge test went up by an
average of two points
“Our PS
awareness
programme is
effective”
Highest Compared to a control group of people
who weren’t exposed to the programme at
all, participants in the programme
increased scores on seven out of eight
measures of PS awareness
Low I talked to John, who participated, and he
said it worked for him
2. Why bother with indicators?
atically collecting programme indicators we
can more precisely measure (and not guess
at) whether the objectives are being met.
More importantly, having good indicators for
our programme enhances our confidence
in claims made about the programme. Con-
sider the example on this page.
In this example, the claim being made by a
programme manager is the same: “Our PS
awareness programme is effective.” But our
confidence level in believing this claim
varies directly with the quality of the in-
dicators (measures) used to support it.
Why bother to use indicators at all? Can’t
we just look at a service or treatment sys-
tem and tell whether objectives are being
met? The simple answer is: NO! In this
area, people are notorious for making poor
“intuitive judgements.” For example, in-
dividuals tend to remember events that
confirm what should happen. They tend to
forget events that contradict what should
happen. People also tend to overgeneralise
from one or two memorable cases to the
overall situation. The best way to avoid
these biases is to systematically collect in-
formation on a regular basis. By system-
By systematic
collection of
programme
indicators, we
can more
precisely
measure (and
not guess at)
whether the
objectives are
being met.
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You Me
For instance, we’d be very suspicious of this
claim if all the manager could say was that
he or she ‘heard it through the grapevine’.
At the other end of the spectrum, we’d
have a lot of confidence in this claim if the
manager could show us that, in compari-
son to a group of people who weren’t ex-
posed to the programme, participants in-
creased their scores on seven out of eight
PS awareness measures. In the first case, the
indicator is poor. In the second case, the
indicator is very good. Thus, having qual-
ity indicators for your programme evalua-
3. The language of measurement
tion greatly increases the confidence you
can have in claims being made on behalf of
the programme.
Once you have chosen the basic indica-
tors for your research questions, you must
select a specific method for measuring them.
Because different methods of collecting data
provide different sources of information,
you must be clear about what you want to
know before you choose a method. As we
have seen above, most indicators can be
measured in more than one way.
of interest, such as a self-reported mea-
sure of number of drinks per day, or a
standardised questionnaire of depressive
symptoms. Data refers to the concrete ob-
servations that you make with respect to
each indicator, in other words, the specific
responses from participants. The relation-
ship among variables, indicators, and data
is shown below.
Let’s define some basic terms. Data col-
lection is about the process of finding or
creating good indicators for programme ob-
jectives and systematically collecting infor-
mation on these indicators. There are three
basic concepts involved in data collection.
Variables refer to the abstract output or
outcome that interests you, such as PSU
problems or depression. Indicators refer
to the specific way you measure variables
Variable
Indicator
A trivial example...
Height
Mark on the wall
[Variable]
Tape measure
[Two indicators]
[Data]
[The abstract output or
outcome of interest]
[Different types of measures
of the output or outcome]
[The specific
observations you make]
Indicator
01 02 03 04 01 02 03 04
You Me
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Client Client ClientClient Client Client
A simple example of relations between vari-
ables, indicators, and data can be given with
respect to measuring height. As a variable,
height is an abstract concept that can be
measured by at least two different indicators:
a tape measure, and a mark on the wall. For
each indicator, we could collect data on your
height and my height. The outcomes we ob-
tain for you and I (inches, using the tape
measure indicator; marks on the wall, using
the pencil indicator) constitute our data for
the height variable.
Treatment services and systems are full of
variables. The trick will be to find or con-
struct good indicators for each of the vari-
ables that are specified in your programme
logic model and evaluation questions. You
must then systematically collect data (obser-
vations) for each indicator. Unfortunately, that
is not as easy as it sounds. For many vari-
ables in programmes, indicators are not as
obvious as in the ‘height’ example.
For instance, the figure below presents a
more complex variable – alcohol use.
What indicators could we use to see
whether people actually change alcohol use
after participating in a treatment
programme? Two indicators that could be
used are questionnaire items assessing fre-
quency of alcohol use and another test
measuring quantity of alcohol use. In this
example, we have one variable (alcohol
consumption) and two indicators of it
(frequency and quantity). If we wanted
to collect data to see whether our
programme accomplished its goal of de-
creasing alcohol consumption, we could
administer the two indicators to clients
before and after treatment. These obser-
vations constitute data that we collect on
the alcohol consumption variable, using the
two indicators.
Alcohol Consumption
Quantity of
alcohol use
[Variable]
Frequency of
alcohol use [Two indicators]
[Data]
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Into action
After generating possible evaluation ques-
tions, the evaluation team decides to con-
centrate their evaluation on coverage at the
activity level and effectiveness of their
AIDS education. An evaluation about ba-
sic coverage at the activity level provides
answers whether their programme accom-
plished what was expected to accomplish.
For example if clients were referred to long
term treatment after their detoxification. An
evaluation of the effectiveness of their
AIDS education provides answers, if this
intervention achieves its objectives. For
example if clients’ knowledge about
AIDS increased after the intervention.
The intervention consists of five 1 hour
group sessions in which clients learn
about the human immunodeficiency vi-
rus (HIV), transmission, prevention,
symptoms, HIV testing and focuses on
personal susceptibility and situational
analysis.
1 Has the number of referrals increased
from the previous year?
2 Did the characteristics of the clients
change in comparison to last years cli-
ents?
3 Has the number of self-discharges de-
creased from the previous year?
4 Has the number of clients who were
referred to long-term treatment in-
creased from the previous year?
5 Did attitudes in favour of HIV low-risk
practices improve among clients?
6 Did client’s HIV-risk behaviour change
in favour of low risk practices after treat-
ment?
7 Did clients knowledge about AIDS in-
creased after the AIDS education inter-
vention?
8 Did clients self-efficacy regarding their
ability to use skills maintaining AIDS
harm reduction behaviours increase?
Review of records
Review of intake form records
Review of termination form records
Review of termination form records
Before/after intervention questionnaire ask-
ing about attitudes towards AIDS.
Before/after intervention questionnaire
asking about risk behaviours.
Before/after questionnaire assessing
knowledge about AIDS.
Before/after questionnaire assessing self/
efficacy.
Main research questions and their indicators
IndicatorsQuestions
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Its your turn (6 B)
2 Select indicators for each of the re-
search questions that your group has
chosen (see Step 5). At this point, do
not concern yourself with exact mea-
surement tools; selection of exact
tools will be addressed below. For
now, just write down using simple
language some reasonable indicators
for your research questions.
1 Test your knowledge. Describe the
following terms to your evaluation
partners:
• Variable
• Indicator
• Data
Provide an example of each from your
PSU programme or treatment network.
4. Quantitative and
qualitative measurement
worker was available. This percentage
would ideally total 100, and provide a
number that summarises information for
the variable. Another quantitative indi-
cator may be the number of days a person
must wait for their assessment. Quantita-
tive indicators are useful because they:
• conveniently summarise a large amount
of data reflecting key objectives of a
programme
• can be easily translated into graphs
which portray the results of an evalua-
tion
• can be analysed using statistical tech-
niques
Qualitative indicators also can be used in
programme evaluation. You are using a
qualitative approach to indicators when-
ever you measure a variable with words.
One distinct advantage of the qualitative
approach is that it can preserve the unique
point of view of the people being studied.
For example, if we are interested in the
variable “well being” as an outcome of
The preceding section distinguishes among
variables, indicators, and data. We see that
for many aspects of PSU services and sys-
tems (unlike for physical properties, such
as height and weight), the variables are
complex. Variables such as PSU aware-
ness, reduction in drinking, consequences
of PSU, self-esteem, motivation, well-be-
ing, and other objectives of programmes
can be measured in several ways. The next
step is to critically think about the differ-
ent types of indicators that are available
to help you measure such complex vari-
ables in your evaluation.
The world of measurement generally
uses one of two different strategies, de-
pending on whether indicators are num-
bers or words. You are using a quantita-
tive approach to indicators whenever the
measurement of a variable is conducted
through numbers. Going back to the ex-
ample used earlier, if one objective of
our programme is to ensure that an as-
sessment worker is available, we could
construct a quantitative indicator of this
objective by computing the percentage
of work days per month in which the
You are using a
quantitative
approach to
indicators
whenever the
measurement
of a variable is
conducted
through
numbers.
You are using a
qualitative
approach to
indicators
whenever you
measure a
variable with
words.
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our programme, we may not have a good
quantitative indicator of well being. A
qualitative option would be to ask clients
about their well being at the end of a
programme. We could do this with ques-
tions about their physical and mental health
and their ability to cope with the stresses
of daily living. We might tape-record their
answers and identify themes that reflect
“well being” and perceptions that it has
changed as a result of programme partici-
pation. In this case, language (not numbers)
provides indicators for the variable(s) of
interest. Because the qualitative approach
relies heavily on words it incorporates the
distinct point of view of the person(s) talk-
ing. Well being may be discussed in vari-
ous ways by different people and cultural
groups.
Review this example: The Timmins detoxi-
fication service evaluation, described in
the back of this workbook, used both quan-
titative and qualitative indicators. The
planners’ rationale for why they chose
qualitative and/or quantitative indicators
for each variable is well described in the
case example.
Its your turn (6 C)
Test your knowledge. Choose whether each of the following variables is quantitative or
qualitative:
1 Number of alcoholic drinks consumed in past 7 days.
2 Total depression score on a self-reported questionnaire of depressive symptoms.
3 Patients’ descriptions of the circumstances surrounding their first use of PS.
4 Age of patients.
5 Gender of patients.
6 Number of different types of PS that patient has used in past 90 days.
7 Patients’ descriptions of their experiences in your PSU treatment programme.
8 Patients’ ratings, on 0 – 10 scale, of their satisfaction with your PSU treatment programme.
9 Clinicians’ reports of the extent of patients’ improvement while in the programme.
10 Clinicians’ ratings, on a 1 - 5 scale, of patients’ improvement while in the programme.
Answers: Quantitative - 1, 2, 4, 5, 6, 8, 10  /  Qualitative - 3, 7, 9
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5. Quantitative indicators: determine
what measurement scales you need
You cannot add or subtract the difference
among values on the scale.
Interval scales provide numerical labels
reflecting a magnitude of differences;
however, you can only add or subtract the
differences among values in the scale. Of-
ten attitudes and beliefs are measured on
interval scales. For instance, you might ask
your staff to indicate their degree of agree-
ment with the statement: “Should people
convicted of driving while impaired be
forced to go to treatment?” on a scale rang-
ing from 1 (strongly disagree) to 9 (strongly
agree). Another common example is cli-
ents= rating of satisfaction with the
programme: (1) very unsatisfied; (2) un-
satisfied; (3) neutral; (4) satisfied; and (5)
very satisfied. Another example might be
to count the number of areas of the client’s
life affected negatively by their PSU. A
client reporting three problem areas (e.g.,
physical health, social relationships and
work) has two problem areas more than
another client reporting consequences in
only one area (e.g., mental health).
Finally, ratio scales provide numerical la-
bels that can handle any mathematical
equation, and include a true zero point. For
example, weight and distance are arranged
on ratio scales. We know that 10 kilometres
is twice as far as 5 kilometres. Figure 8
summarises the four levels of quantitative
measurement. The figure contains useful
reminders of the types of information that
can be derived from using these types of
indicators.
Depending on your specific evaluation ques-
tion, quantitative data are available from a
variety of sources, including observation,
questionnaires, interviews, and record re-
views (reviewed in point 8 below). Regard-
less of how you obtain quantitative indica-
tors, if your evaluation is attempting to provide
numbers for key variables in your program,
you need to determine the kind of quantita-
tive scales that should be used to collect the
data. A scale is simply a classification scheme
for describing the nature of your observa-
tions. There are four basic types of quantita-
tive scales. You will probably use a combi-
nation of them in quantitative programme
evaluation:
Nominal scales provide labels for the data
you collect. A simple example would be
to assign different numbers for hair
colours: red, black, blond, brown, and so
on. Many variables in a programme evalu-
ation can be labelled using a nominal
scale. For instance, if you want to track
the number of men and women in your
programme in a given time period, you
could assign the number 1 for males and 2
for females. The important thing to note
about nominal scales is that they are mu-
tually exclusive. That is, you can’t be both
male and female, both blond and red-
haired, and so on.
Ordinal scales are arranged according to
a ranking (e.g., few —— many; bad ——
good). One commonly used ordinal scale
in programme evaluation is socio-eco-
nomic status. One scale might assign the
value 1 to people at a low socio-economic
class, 2 = middle class, and 3 = upp er class.
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Four types of scales
Level of measurement Type of information
Nominal Two or more unordered categories
e.g., Did your spouse influence your decision
to enter treatment?
          YES               NO
Ordinal Two or more ordered categories
e.g., Rank of sources of motivation to enter treat-
ment (e.g. family, employer, courts...)
          Rank 1      Rank 2       Rank 3
Interval Numerical labels reflecting magnitude of
differences
e.g., 1 = strongly disagree  /  9 = strongly agree
Ratio Continuous scale, true zero point
e.g., How may drinks did you have in the past
week?
                drinks
1 932 54 76 8
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6. When should you use qualitative
and quantitative measurement?
One issue that arises in programme evalua-
tion is determining when each measurement
strategy is appropriate. The question is:
when do you use numbers (quantitative ap-
proach) and when do you use language
(qualitative approach)? One good rule of
thumb is to use quantitative indicators
whenever you already have a good idea
about how to measure the output or out-
come of interest in your programme evalu-
ation. There are several ways to do this.
Perhaps the best way is to take advantage
of someone else’s previous work and use
their scale or indicator for the output or
outcome. The workbooks that are part of
this series offer advice on quantitative mea-
sures that can be used to measure client
characteristics, treatment process, client
satisfaction and outcomes. If you do
enough background research and library
work, you may be able to find a
standardised measure or scale that can be
used in your evaluation. However, it is im-
portant to be sensitive to the fact that mea-
sures that are deemed to be useful in a
certain culture may not be valid or useful
in other cultures. If you can’t find an ap-
propriate measure for your setting, then you
may have to create something new. This situ-
ation is discussed later in this workbook.
What if you don’t have a good idea about
how to measure the output or outcome
quantitatively? Qualitative methods can
help. For example, if your search of the
literature did not result in finding a cultur-
ally appropriate, quantitative measure of
“PSU,” you might want to approach the
measurement issue from a qualitative point
of view. This could be done by interview-
ing programme participants about this vari-
able. This approach has the advantage of
not presuming what ‘PS consumption’ is
for the respondents. It allows them to in-
troduce their own unique interpretation of
the variable, which may better reflect their
unique situation and culture.
Other factors affecting whether you use
quantitative or qualitative methods in your
programme evaluation are (a) the degree
to which you have expertise and/or train-
ing in each method, and (b) the resources
(time, staff) available to you.
7. Reliability and validity
As mentioned earlier, your confidence in
making claims about the programme in-
creases as the quality of the indicators
and data used to measure programme
variables increases. But how do we de-
termine our confidence in the measures
used? Regardless of whether the mea-
surement strategy adopted in your
programme evaluation is quantitative or
qualitative, measures that you use in col-
lecting data about your evaluation ques-
tions must be both reliable and valid.
Reliability
This refers to whether an indicator is con-
sistent across time and observers. A
simple example would be to consider a
thermometer. A reliable thermometer,
when plunged into boiling water, should
give the value of 100 degrees centigrade.
Further, if the instrument is truly reliable,
it should give the same measurement ev-
ery time it is plunged into boiling water,
no matter who is viewing the temperature.
Reliability refers
to whether an
indicator is
consistent
across time and
observers.
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Clearly, our confidence in the indicator (the
thermometer) decreases if different results
are obtained each time we take it in and
out of this same water. The same situation
is true for indicators designed to answer
your specific evaluation questions. For
some indicators (e.g., gender, income, edu-
cation), reliability of the measures may not
be compromised. That is, unless respon-
dents are lying or misinterpreting the ques-
tion, you can be relatively confident that
data collected on these indicators is reli-
able. Reliability is not so easily estab-
lished, however, for more complex vari-
ables, such as reduction in alcohol use,
self-esteem, PS awareness and quality of
life. One advantage of using existing indi-
cators (e.g., quantitative scales, qualita-
tive interview schedules), is that it is likely
that they have been tested previously for
reliability.
For most subjective and objective outcome
measures, an individual should answer
questions in the same way if the question
is asked more than once within a short pe-
riod of time. This is called test-retest re-
liability. If this pattern does not occur for
most observations, the indicator is prob-
ably unreliable. As part of a pilot test of
your evaluation, you might want to con-
duct a test-retest study using a small num-
ber of people who are similar to those who
respond to your final evaluation. This ap-
proach will determine the consistency of
their responses.
In the case of qualitative data, you should
use two different people to analyse the in-
formation to see if they identify the same
themes. For example, a client may have
been asked to describe her perceptions of
how treatment has affected her life. If two
people analyse the transcript of the inter-
view and both identify a theme of “losing
friends after treatment” then the result
would be reliable. This concept of reli-
ability is called inter-rater reliability,
and refers to the ability of independent rat-
ers to agree on measurements provided by
indicators.
You may also want to build reliability/con-
sistency checks into a questionnaire. You
can do this by including several questions
which people would be expected to an-
swer the same way. For example, a mea-
sure of client satisfaction could ask respon-
dents to indicate how pleased they were
with the programme, how much they en-
joyed the programme, and areas of the
programme that were problematic. A high
proportion of inconsistent ratings on these
dimensions would indicate that the items
are unreliable. This concept of reliability
is called internal consistency.
Validity
An indicator may be reliable and yet not
be at all valid. Returning to the thermom-
eter example, if the thermometer consis-
tently reports a temperature of 110 degrees
centigrade every time it is put into boiling
water, it is reliable, yes, but invalid (since
water boils at 100 degrees, not 110 de-
grees). Validity concerns the extent to
which you are actually measuring what
you intend to measure in your
programme evaluation. As another ex-
ample, your interview (or qualitative) in-
dicator of self-esteem would have low
validity if it just measured how much the
respondent liked the interviewer. As in
reliability, the more valid your indicators,
the more confidence can be placed in the
data collected on those variables.
Several kinds of validity can be deter-
mined for indicators used in a programme
evaluation. Face validity refers to whether
the content of the specific questions or mea-
sures reflect what the indicator is supposed
to measure. For example, asking a question
such as “How well did you like the other
clients in the programme?” would have poor
face validity if the indicator is really sup-
posed to measure client self-esteem.
An indicator can also be validated by com-
paring it to a known measure of the same
variable. The result is called concurrent
validity.
Validity
concerns the
extent to which
you are
actually
measuring
what you
intend to
measure in
your
programme
evaluation.
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The validity of qualitative indicators can be
established by (a) providing concrete ex-
amples of themes identified in written mate-
rials, (b) demonstrating that the people re-
sponding to the interviews were not
attempting to lie or deceive, and (c) relating
themes identified to other indicators that
enhance confidence in your interpretation
of the materials.
In summary, paying serious attention to the
reliability and validity of your indicators
can greatly enhance confidence in any
claims made during the course of a
programme evaluation. When you use re-
liable and valid indicators, people will
put much more weight on your conclu-
sions than if you used indicators with
low reliability and validity. Often, you
can use existing instruments that have
been tested and fine-tuned to increase
reliability and validity. When this op-
tion is available to you, it is preferable
to use existing indicators (e.g., scales,
interview schedules, as opposed to de-
veloping new tools).
Its your turn (6 D)
1 Describe reliability and validity to your evaluation partners. Explain why each is impor-
tant in your choice of measures.
2 As a group, complete the following exercise:
A driver is stopped by the police for suspicion of driving under the influence of
alcohol. Which of the following measures is a reliable and/or valid indicator of the
driver’s level of intoxication?
Measure                                                                           Reliable?    Valid?
Driver’s report of number of drinks he/she had that night
Performance on tests of motor co-ordination
Blood alcohol level
Eye colour
3 Think of at least two other reliable and valid measures of PS intoxication.
Answers to question 2
Measure Reliable? Valid?
Driver’s report of number of drinks he/she had that night Yes No
Performance on tests of motor co-ordination Yes Yes
Blood alcohol level Yes Yes
Eye colour Yes No
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8. Types of measures
A final measurement concept concerns the
different types of measures that you can
use in your research. Each method has ad-
•  Observation
Observation is
a procedure for
gathering
information by
carefully
watching and
writing down
the behaviour
of individuals
or events.
Questionnaires
are useful
when you want
to collect a
small number
of clearly-
defined facts
from a large
number of
people.
vantages and disadvantages (explained be-
low). Different measures may be more or
less appropriate for different studies.
Observation is a procedure for gathering in-
formation by carefully watching and writing
down the behaviour of individuals or events.
Researchers choose the time and place of
the observation so that they will have a good
chance of seeing the people or behaviour that
they wish to observe. Usually people or
groups are observed repeatedly to make
certain that the observation is complete and
accurate. The observers may record every-
thing that they see, or they may only record
certain variables such as number of alcoholic
drinks consumed.
For the observations to be useful in an
evaluation, it is essential that staff use a
standard protocol for recording them. Rat-
ing forms completed before treatment and
at various points during and after treatment
can be used. Staff must be carefully trained
to ensure that they all use the observation
procedures the same way. That is, if sev-
eral staff members interview the same cli-
ent on the same day and fill out an obser-
vation from, you would want to be confident
that their observations or ratings have high
inter-rater reliability. Otherwise, your find-
ings will be unreliable. For example, some
counsellors consider “engagement or in-
volvement in the treatment process” to be a
useful indicator of client progress and a pre-
dictor of relapse; an instrument could be de-
signed to rate client involvement over time.
If the instrument were reliable and valid,
the results could be subsequently corre-
lated with information about relapse or re-
duced drinking to test the hypothesis that
client involvement predicts outcome.
Observation is a good way of checking the
validity of information learned through
questionnaires or interviews. Observing
behaviour allows you to confirm these
statements.
On the other hand, observation is time-in-
tensive, and does not allow you to under-
stand participants’ thoughts and feelings.
•  Questionnaires
A questionnaire is a written set of questions
that a participant answers by writing in the
spaces provided on the same sheet. Question-
naires are often self-administered. This means
that the research participant reads the instruc-
tions and completes the questionnaire with little
help from the investigator.
Questionnaires can include closed-ended
questions, in which participants must
choose from a list of possible answers,
and/or open-ended questions, in which no
specific answers are provided: people can an-
swer any way they choose. Closed-ended
questions are usually quantitative, while open-
ended questions are usually qualitative.
Questionnaires are useful when you want
to collect a small number of clearly-de-
fined facts from a large number of people.
They may be a good choice when you want
to gather information about sensitive top-
ics, such as sexual behaviour. Some people
will feel more comfortable answering a
written question than talking to an investi-
gator face to face.
36 Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2b
A major disadvantage of questionnaires is
that only people who read and write can
use them. If you know or suspect that
many clients have reading problems, do
not use self-administered questionnaires.
Be alert for signs that a client may be
having difficulty understanding the in-
strument. Be prepared to help such cli-
ents by having a staff member read the
questions. An additional disadvantage is
that participants may get caught in a re-
sponse set — that is, they may answer
a series of questions in the same way
without thinking through each one.
•  Focus group discussions
•  Interviews
Interviewing involves meeting face to face
with an interviewer, who asks the person
specific questions and records the person’s
answers. Questions may be open-ended or
closed-ended.
Personal interviews offer several benefits.
They avoid difficulties associated with
reading problems. They permit you to
probe for in-depth information and to con-
tinue a particular line of questioning when
appropriate. If an item is failing to work
as expected, an interviewer may recognise
a problem that would not be obvious from
self-administered instruments. An inter-
viewer can make sure that identifying in-
formation that links one instrument to an-
other — for example, to link a client’s
satisfaction survey to a record of the
client’s time in the programme — is filled in
completely and accurately.
Interviews can be subject to the same re-
spondent biases as self-administered ques-
tionnaires. For example, tendencies to a
response set and giving socially desirable
answers can occur in interviews as well as
in self-administered questionnaires. They
can also be subject to interviewer bias and
interview error. For these reasons, inter-
viewers must be trained. Interview time
involves cost considerations. Costs are
highest for personal interviews, less for
Personal
interviews offer
several
benefits.
telephone interviews, and comparatively
modest for group interviews.
Interviews done in person usually produce
a slightly higher response rate than tele-
phone interviews, but they are more costly.
Telephone interviews, while less costly,
have two potential problems: not all cli-
ents may have telephones, and privacy and
confidentiality may be difficult to ensure.
Clients may also be reluctant to talk or give
honest answers if family members or co-
workers are present during their telephone
interviews. Also, the typical telephone in-
terview is shorter than a personal interview.
Group interviews can be conducted by hav-
ing an interviewer read questions from a
self-administered form while clients record
their responses on their own form. This is
a practical approach to improving response
rates and addressing low literacy, without
the time and expense of personal inter-
views.
If your programme staff is conducting in-
terviews, they should be trained carefully.
They should know such interviewing tech-
niques as ensuring confidentiality to re-
spondents, maintaining objectivity, asking
questions exactly as stated, recording re-
sponses properly and legibly, probing, es-
tablishing rapport, and being sensitive to
the cultural values of respondents.
Focus groups
are best seen
as a way to
identify issues
and clarify
concepts.
Another interview format that can be used is
a focus group, which is a general discussion
between 7-8 individuals on a selected topic.
Focus groups usually last for one to two
hours. They are run by a trained moderator
whose function is to guide the discussion. The
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information about many different variables
not all of which are relevant for your evalua-
tion. It is also difficult to establish reliability
and validity of focus group data. For these
reasons, focus groups are more useful for
certain types of evaluation activities (e.g.,
planning an evaluation, needs assessment)
than others (e.g., outcome evaluation and/or
economics).
Specific instructions for using the focus group
method are outlined in Appendix 1 of this
workbook.
overall aim of focus group interviews is to
provide an understanding of the thoughts and
feelings of participants as they consider an
issue (e.g., an aspect of your programme).
Focus groups are best seen as a way to iden-
tify issues and clarify concepts. Transcripts
of focus groups can be used to supplement
programme evaluations by providing in-depth
accounts of participant reactions to an issue.
It would be unwise to rely on focus groups
as the sole source of observations for your
programme evaluation. This is because fo-
cus groups are open-ended and can provide
•  Examining Routine Records
You may obtain useful records for measur-
ing programme processes and outcomes from
your programme files. Increasingly, this in-
formation is available through computer in-
formation systems. Relevant information may
also be accessible from other treatment
programmes that may treat some of your cli-
ents, such as from school health, social ser-
vice records, or police or court records. In-
formation routinely submitted to government
from all treatment agencies in your jurisdic-
tion may also be accessible.
Three types of instruments commonly used
in treatment programmes for PSU disor-
ders are used for programme evaluation
intake records, case notes, and termina-
tion forms. The intake data may contain a
brief client-flow or census form, a gen-
eral background and behavioural history
assessment. It may also contain a more
extensive diagnostic assessment battery.
The data are typically collected by an in-
take worker, treatment counsellor, or
records clerk in one or more interview
sessions. Case notes may contain infor-
mation designed to document how a client
has adjusted and made progress in chang-
ing behaviour. The notes can also include
information obtained on schedule to assess
domains of treatment process and client
progress over time. The treatment termi-
nation form shows the time of, and reasons
for, a client’s discharge.
Existing data from other agencies is less ex-
pensive to use in evaluation than data ob-
tained directly from the client in a self-report
or interview format. This is because the in-
formation has already been collected. How-
ever, since the data were collected for other
purposes, they may contain biases that are
difficult to discover. If you ask other agen-
cies for access to their records, you must be
very specific about what information is
needed, what analyses will be done, and how
the confidentiality of records will be pro-
tected. You must also indicate to whom the
results will be reported.
Formal request for access to records is
only part of the process. You may want to
meet informally with the agencies’ man-
agers before you submit a written request.
Offer to meet with the organisation’s staff
to work out procedures to get the data in
the least disruptive way possible. Get the
name of a contact person who can answer
future questions about how to interpret the
data, and develop a working relationship
with the contact person as soon as pos-
sible. You will need the organisation’s co-
operation. Collecting data often takes sev-
eral months, and learning how to use it may
take time. Request access to records or
archival information ahead of when you
actually need it.
Existing data
from other
agencies is
less expensive
to use in
evaluation than
data obtained
directly from
the client in a
self-report or
interview
format
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Into action
The evaluation team thought about the fol-
lowing types of measurement for their re-
search questions.
1 Has the number of referrals increased
from the previous year?
2 Did the characteristics of the clients change
in comparison to last years clients?
3 Has the number of self-discharges de-
creased from the previous year?
4 Has the number of clients who were re-
ferred to long-term treatment increased
from the previous year?
Type of measurement: To answer ques-
tions 1-4, the team would use their in-
take records and termination forms.
Their intake data contains information
about each client relating to age, gen-
der, marital status, education, source of
referral, involvement in health and jus-
tice system, general mental and physi-
cal health and their individual drug his-
tory including adverse consequence of
their PSU use and risk behaviours.
Their treatment termination form in-
cludes the time of, reasons for client’s
discharge and if the client was referred
to any long-term treatment.
5 Did attitudes in favour of HIV low-risk
practices improve among clients?
Type of measurement: The team agreed
upon using attitude scale (question-
naire) assessing perceived susceptibil-
ity to AIDS, benefits of risk reduction,
attitudes towards slips in drug-use and
sexual risk behaviour. The scales cho-
sen are interval scales. The client has
to indicate his/her degree of agreement
with statements about AIDS on a scale
ranging from 1 (strongly disagree) to 4
(strongly agree).
6 Did client’s HIV-risk behaviour change
in favour of low risk practices after
treatment?
Type of measurement: The team de-
cided to assess HIV-risk behaviour by
using a questionnaire asking about risk
behaviours associated with drug use
and administration and sexual risk
behaviours (see sample questionnaire
about risk behaviour, appendix 2). The
level of measurement would be nomi-
nal, e.g. Have you ever shared a needle,
syringe/ spoon/ cooker or cotton/ filter
with anyone at any time in your life?
and interval, e.g. during the past 90 days
how many days did you inject any kind
of psychoactive substance?
7 Did clients knowledge about AIDS in-
crease after the AIDS education inter-
vention?
Type of measurement: Knowledge
scales assessing knowledge of methods
whereby HIV is transmitted, methods
for prevention of transmission and un-
derstanding of the HIV antibody test.
The level of measurement of this scale
would be nominal. The number of cor-
rect responses to Yes/No items (0-15)
would be recorded.
8 Did clients self-efficacy regarding their
ability to use skills maintaining AIDS
harm reduction behaviours increase?
Type of measurement: Scales assess-
ing self-efficacy regarding cleaning in-
jection equipment with bleach and us-
ing condoms. The level of measurment
would be nominal. Clients would have
to indicate their degree of confidence
(1 = not at all confident - 4 = extremely
confident) regarding five behaviours.
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Its your turn (6 E)
With your group, discuss what type(s) of
measurement (e.g., questionnaires, record
review) you would use for each of the fol-
lowing research questions, and why:
1 Did patients who reported prior sexual
abuse finish the programme more often
than those who reported no abuse?
2 Did patients who completed the
programme decrease their PSU?
3 What are the attitudes among community
members about our treatment
programme?
Now what? Take a deep breath. You have
just completed the primer on measurement
concepts! Now it’s time to carry forward
with the important task of selecting or pre-
pare a data collection instrument.
Select or prepare a data collection in-
strument. It is important to note that your
data collection instrument can contain com-
binations of qualitative and quantitative
measures taken from existing scales, indi-
cators obtained from other sources, newly-
created measures, and interview questions.
Several PSU-related questionnaires are
contained in the back of this workbook, in
Appendix 2. Here is a very simple data
collection instrument:
A simple data collection instrument (Not validated or reliable)
1 Program                                                1 Detox              2 Residential
2 Client age years
3 Client education (highest level attained)
4 Days employed in past six months
5 Rosenberg Self-Esteem Score
6 Alcohol Dependence Scale Score
7 Aspect of the treatment programme liked best:
8 Aspect of the treatment programme liked least:
Quantitative
indicators
(for 6 variables)
Qualitative
indicators
(for 2 variables)
As you can see in from this figure, this instru-
ment contains two main sections. One sec-
tion records data for six quantitative variables
(program, client age, client sex, client edu-
cation, days employed, self-esteem score
and alcohol dependence score). Note that
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some of the indicators are relatively simple
(age, sex), while other indicators in this sec-
tion consist of reliable and valid measures that
have been used in previous research (e.g.,
Rosenberg self-esteem score; Score on the
Alcohol Dependence Scale). A second sec-
tion of this data collection instrument con-
sists of client responses to questions about
aspects of the treatment programme they
liked most and least. Space is presented on
the form to record the language the client used
to describe these variables. This part of the
data collection instrument measures qualita-
tive information.
Tips for developing questions for
your data collection instruments
Sometimes you cannot rely on existing in-
struments, scales, forms, or interview
schedules to create your data collection
instrument. This section provides tips for
constructing questions that can be used in
either quantitative or qualitative data col-
lection. It is worth repeating that there are
many advantages to using existing instru-
ments that have been proven to be valid
and reliable. Be sure, however, that they
collect the data you need, and that they are
applicable for your culture and/or setting.
In addition, be aware that any revisions
you make to existing instruments such as
rewording, eliminating, adding, or reor-
dering items may diminish the validity and
reliability of an established instrument. If
you must design a new indicator or ques-
tion, here are some tips for constructing it:
• Be sure that the question collects data
on the measures needed for your evalu-
ation questions.
• If pre-test and post-test items are used
to measure change over time, measure
items that are sensitive to change. Also
measure items that different clients are
likely to answer differently before treat-
ment than after treatment. For example,
ask How many days last month did you
use cocaine? rather than Have you ever
used cocaine?
• Divide questions in which two or more
different or conflicting concepts are
presented at the same time. Otherwise
the answers will not be meaningful be-
cause some respondents will answer
one question and others the second. For
example:
(Avoid) How do you rate the comfort
and convenience of the group therapy
sessions?
(Use two questions instead): How do
you rate the comfort of the meeting
area for the group therapy? How do
you rate the convenience of the time
that groups are scheduled?
• Use an “other” category when it is not
practical to provide respondents with
an exhaustive list of response catego-
ries. For example, if you want to know
the job positions of treatment staff, list
only commonly held positions and let
those who do not fit those categories
specify their positions. If enough com-
mon answers are noted in analysis of
the “other” category, each can be given
a code for purposes of analysis. Alter-
natively, you can use footnotes to give
examples of the “other” positions.
• Use open-ended questions sparingly since
they require an extensive amount of time
to interpret, classify, and code. (An open
ended-question does not include response
categories such as yes/no, or a list of an-
swers from which the respondent can
choose.). Rather, it is a broad question
for which an infinite variety of responses
might be given — for example: What has
motivated you to come for treatment?
• Whenever possible avoid skip patterns,
because some respondents find them
confusing and others will ignore in-
structions and respond inappropriately.
A “skip pattern” refers to instructions
to skip certain questions that do not ap-
ply to the respondent. For example, an
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intake from containing questions about
alcohol use and pregnancy would usually
contain instructions for male clients and
women who had never been pregnant to
skip ahead. If the use of skip patterns
seems warranted because items will ap-
ply only to part of the respondent sample
make the instructions as clear as possible.
• Tailor the language used to the reading
level of the respondents. If reading lev-
els range considerably, items should be
worded so that they can be answered
by persons with different skills.
• Make certain that the wording of items
is sensitive to gender, age, ethnic, and
cultural differences in interpretation.
• Most important, remember to keep your
data measurement as simple as pos-
sible. Do not collect information you
do not need.
The second case example located in the
back of this workbook describes the de-
velopment of a new data collection instru-
ment: The Maudsley Addiction Profile
(MAP). The evaluators designed the MAP
to be used in treatment outcome evalua-
tions. It assesses several domains, includ-
ing substance use, risk behaviour, and so-
cial functioning.
The figure bellow summarises several key
points to remember if you decide to write
your own questions as part of a qualitative
or quantitative programme evaluation.
Writing good questions:
a checklist for quick reference
1 Are the words simple, direct and
familiar to all?
2 Is the question as clear and spe-
cific as possible?
3 Is it a double question?
4 Does the question have a double
negative?
5 Is the question too demanding?
6 Are the questions leading or bi-
ased?
7 Is the question applicable to all re-
spondents?
8 Is the question objectionable?
9 Will the answers be influenced by
response styles?
10 Have you exhausted the response
alternatives?
Its your turn (6 F)
1 With your group, create the data collec-
tion instrument using the indicators you
need. Use the information from the primer
and the checklist above to guide your de-
cision-making. While preparing the instru-
ment, decide what method(s) you will use
to collect the data (e.g., interview, ques-
tionnaire, record review).
2 Review your data collection instrument in
light of your original research questions.
Are you asking the right questions?
3 Review your data collection instrument
with the expected users of the research.
Revise as needed.
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Step 7
Prepare a data
collection plan
After selecting measures, you also need to
develop an evaluation design. An evaluation
design is a set of instructions about when and
from whom to collect data. The evaluation
design should be sound, so that you can be
confident in the conclusions that you make
from you research results. For example, a
good design will increase the confidence that
your patients are improving, and/or that the
programme itself is producing the results.
Workbooks 3 through 8 present detailed
information about how to conduct dif-
ferent types of research. You should con-
sult the workbook that is applicable for
your project.
   If you are conducting a...        Then you should review...
Needs Assessment Evaluation Workbook 3
Process Evaluation Workbook 4
Cost Evaluation Workbook 5
Client Satisfaction Evaluation Workbook 6
Outcome Evaluation Workbook 7
Economic Evaluation Workbook 8
If you are not sure what type of evaluation you are conducting, review
the Framework Workbook to determine your evaluation type.
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Into action
After selecting their measures, the team dis-
cussed their evaluation design. Adam S., the
researcher explained to the other team mem-
bers that they need to think about a set of
instructions about when and from whom to
collect the data. He explained to them that
according to their research questions, they
were planing a process evaluation and an
outcome evaluation. Their process evalua-
tion posed questions regarding to coverage
at the activity level of the service. For ex-
ample, they wanted to know what propor-
tion of clients completed the detoxification.
Outcome evaluation relates to the ques-
tions regarding the effectiveness of their
AIDS education. Adam S. explained that in
order to evaluate the effectiveness of this in-
tervention, the best design option would be
a randomised control trial. One group of cli-
ents would be randomly assigned the AIDS
education intervention and one group of
clients would not receive this intervention.
However, in view of the available re-
sources, the team would have to choose a
pre-post design, whereby clients who at-
tend the programme would be assessed
before and after they completed the inter-
vention. This design would not control for
competing explanations for changes in HIV
risk behaviours, however it could de-
termine if the objectives of this inter-
vention were achieved.
Its your turn (7 A)
1 Determine what type of evaluation (e.g.,
needs assessment, client satisfaction)
you are doing.
2 If you have not already done so, review
the appropriate specialised workbook
to assist you with choosing your re-
search measure(s) and developing your
data collection plan.
It is important
to allow
enough time to
pass for data
collection.
Set a time frame for data collection
As part of your overall evaluation, you must
define a period for data collection. It is im-
portant to allow enough time to pass for data
collection. Exactly how much time depends
on several factors. You must consider what
type of change you want to measure. For
process evaluation, this will often be a 6-12
month period long enough to measure
programme operations, but short enough to
answer your evaluation questions in a rea-
sonable period of time. For outcome moni-
toring, at least a six month follow-up should
be planned; often, longer time frames are
required, because some behavioural changes
in clients take a long time. An even longer
period is required to determine whether
changes in behaviour are more than tempo-
rary in nature. Outcome evaluations be-
tween two and five years are common. One
option is to plan for an initial evaluation
period in which you collect data (e.g., 6 or
12 months), and after analysing the results,
develop a plan to extend the data collection
period.
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Into action
the present year and the previous year in or-
der to do a comparison.
For the outcome evaluation, the team
planned a one-year data collection period.
In the course of this year, all clients at-
tending the AIDS education intervention
would be interviewed at the second day
of their detoxification about their knowl-
edge, high-risk behaviour and attitudes
about AIDS (baseline interview, T0). One
follow-up would be conducted, six month
after the first contact with the client (T1).
Because of
limited resources,
you will have to
base conclusions
about the
programme on a
subset of all the
possible outputs
and outcomes
that can be
measured during
a data collection.
The team decided to conduct a process
evaluation and an outcome evaluation. The
next step would be to define a period for
data collection for each evaluation.
For the process evaluation the team estimated
a period of 4 months. By the end of the year,
the secretary would have enter all intake and
termination forms into the central database.
In the following 3 months Adam S. would
then calculate number of referrals, dropouts,
and referrals to long-term treatments and
mean values for client characteristics for
Its your turn (7 B)
1 Using the appropriate specialised manual
as a guide, choose your time frame for
data collection.
2 Review your data collection time frame
in light of your original research ques-
tions. Does your time frame adequately
address your questions?
Determine the sample you will use
After you have determined an appropriate
period for data collection, the next step is to
determine how the data collection instrument
will be used. It should be obvious that no
data collection can go on forever. In fact,
every programme evaluation has limited re-
sources and time. Because of limited re-
sources, you will have to base conclusions
about the programme on a subset of all the
possible outputs and outcomes that can be
measured during a data collection. Limita-
tions on resources and other practical con-
siderations also mean that you will only col-
lect information from a subset of the people
involved with your programme, including your
clients. The following basic statistical con-
cepts will help you here. Populations and
Samples: A population refers to all of the
variables of interest for a particular evalua-
tion question. For example, the population
of suicides in your community refers to all
the suicides that have occurred — every one
of them. Another example might be the popu-
lation relapses after attending your
programme — again, the population refers
to every single relapse that could be mea-
sured. Any summary of quantitative infor-
mation produced for the entire population of
3 Review your time frame with the expected
users of the research. Revise as needed.
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outputs and outcomes is called a parameter.
Any qualitative summary information we
produce for the population is called an ideal
type. For example, if we had access to the
self-esteem scores of all the clients who ever
participated in our program, we could gen-
erate the average self-esteem score among
the population of clients served by our pro-
gram: a parameter. Alternatively, if we
summarise a single theme reported by the en-
tire population of clients, this represents an ideal
type.
Because we typically don’t have time or
resources to measure all the observations,
a sample refers to those individual vari-
ables that are actually examined in the
course of data collection. For example, be-
cause we don’t have enough money to mea-
sure the population of outcomes for your
programme (i.e., every client who has
passed through the door) we take a sample
of clients — for instance, all of the clients
who leave the programme in a six-month
period. In this case, we must base any con-
clusions or claims about client outcomes
in the population on just the six months
of data collected in our sample. If we
have a representative sample, a sample
of measured outputs and outcomes that
closely mirrors the larger population, our
confidence in our data increases.
Six different ways to sample a population:
ACCIDENTAL Man-on-the street method — weakest method with many
sources of bias
REPUTATIONAL Selection depends on someone’s judgement of who is and
who isn’t a “typical” representative of the population (e.g.,
surveying agency directors about their organisation)
RANDOM Every output or outcome has an equal chance of being
selected and included in the sample. Clients are picked
through a random procedure.
STRATIFIED If you want to make sure certain sub-groups are included
then sample within each group (e.g., assessing needs of
organisation make sure you have programme staff, cleri-
cal staff, secretarial staff, etc.)
CLUSTER Used if population spread out in order to keep costs down
if face-to-face interviews used (e.g., randomly select two
programs and survey in only these two)
QUOTA Sometimes used if you have limited resources but want a
“quick reading” of the population (e.g., say client popu-
lation is 70% males and 30% females. A sample of 100
people could be drawn - 70/30.)
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Sample size and power of your study
Researchers are very good at dealing with
methodological and procedural issues in
their investigation. However, they quite
frequently fail to address power and
sample size: On the assumption that the
research hypothesis is true, it is necessary
that the investigators determine the sample
size needed to give this hypothesis a rea-
sonable chance of being proven correct.
A power analysis of one’s planned inves-
tigation provides the researcher with the
number of subjects needed (N) to achieve
a desired power of the study or estimates
the power of the study if a sample size is
already given. For the calculation of N or
power you need to know the following
components:
1 Sample size of your study
2 Power or the odds that you will observe
a treatment effect when it occurs.
3 Critical Effect size: This is a measure of
how strong a theory must minimally be to
be “important to society”. The specifica-
tion of this measure is based on your re-
search design and your population char-
acteristics under investigation. A
statistician will assist you in specifying this
measure.
4 Alpha error (, or significance level) or the
odds that the observed result is due to
chance.
Given values for any three of these com-
ponents, it is possible to compute the value
of the fourth. For instance you might want
to determine what a reasonable sample size
would be for your study. A statistician will
be able to calculate the power or sample
size of your study, if you provide him with
these components, which have to be as-
sumed in advance of your study. They de-
pend on your research design and on the
statistical analysis you plan to conduct.
The statistician will also assist you with
estimating the components (e.g. effect size),
if you explain him your design.
Few studies discuss how the number of pa-
tients who took part in the study was de-
cided. Often this number seems to have been
arrived at by some consideration of admin-
istrative convenience. However, using too
many patients will almost certainly be a waste
of time and money. On the other hand, too few
will lead to insufficient power of a study. In or-
der to understand the meaning of power, it is
important to know the following statistical terms:
In every statistical analyses there are two
hypotheses under consideration:
The null hypotheses assumes that the vari-
able being investigated is without effect
(e.g. treatment intervention will not af-
fect the quantity and frequency of alco-
hol consumption) and the data you are
collecting are given the opportunity to
disapprove this assumption. If you can
reject the null hypotheses, then your re-
search hypothesis which is the reason
that the investigators did the study is ac-
cepted (e.g. treatment intervention leads
to reduction of alcohol consumption).
The basic overall principle is that the
research hypothesis is considered false
until demonstrated beyond reasonable
doubt to be true. What is considered a
“reasonable “ doubt is called the alpha
error or significance level. By conven-
tion in scientific research, the alpha er-
ror or level of remaining doubt is one
below either 5% or 1%.
The error in rejecting the research hy-
pothesis when true is called beta error.
This value should be as small as pos-
sible. The value 1-beta is called power
and we wish that value to be as large as
possible. Power is the probability of
obtaining a significant result (i.e. reject-
ing the null hypothesis) on the assump-
tion that your research hypothesis is true.
In other terms, power is the sensitivity
of the study to detect clinically impor-
tant differences or effects.
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To give you an example of what information
is necessary in order to calculate the power
of a study, imagine the following scenario.
You want to find out if a group of methadone
maintenance clients consume on average sig-
nificantly less units of alcohol after receiving
a certain treatment (e.g. motivational inter-
viewing) compared to a group of methadone
maintenance clients who did not receive
motivational interviewing. The statistician
needs to know:
• Alpha level = .05. You want to be 95%
certain that your observed difference
are not due to chance.
• Effect size = .833
• Sample size per group, e.g. N = 5
With this information you statistician will tell
you that you have only a 42% chance of de-
tecting a clinical important difference, assum-
ing it exists (= power of your study). How-
ever, a rule of thumb in social research is that
you want a statistical power of at least 80%.
That is, you want to have at least 80 chances
out of 100 of finding an effect when there is
one. All mentioned factors in this example
are interrelated with power. Changes in any
one of these factors will lead to a change in
power. You can also calculate what sample
size you will need in order to have a power
of 80%. In our example, a power of 82%
would be achieved if the number of clients
per group was increased to 20. Again, you
should consult a statistician to assist you with
calculating the sample size for your study.
There are also specialised software
programmes which can conduct a power
analysis (e.g. nQuery Advisor 2.0).
Into action
The next step was to determine the sample
and sample size of the two evaluation
projects. The number of clients for the pro-
cess evaluation would be determined by the
number of clients who entered the treatment
for the present and previous year.
All clients who enter the treatment an initial
assessment form and termination form is
completed and this data is entered to the main
database of the programme. The number of
clients for the outcome evaluation would be
determined by the number of clients who
complete the AIDS education intervention dur-
ing the year of data collection and who would
be able follow up after a period of 6 months.
All clients who enter the treatment have to par-
ticipate in the AIDS education intervention. Ap-
proximately 430 clients attend the service ev-
ery year. If it is assumed that only 60% of clients
will be able to follow-up after 6 months, 270
clients are expected to participate in the out-
come evaluation. Adam S. conducted a power
analysis, which revealed that the study would
have a power of over 80% if this sample size
was assumed.
Its your turn (7 C)
1 Using the appropriate specialised workbook
as a guide, determine the sampling strategy
that you will use to collect your data.
2 Review your sampling strategy in light of
your original research questions. Are you
addressing your questions adequately?
3 Review your sampling strategy with the
expected users of the research. Revise
as needed.
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Step 8
• fees, salaries, etc. for consultants and ex-
tra staff
• non-salary costs such as printing ques-
tionnaires or standard forms, data en-
try, editing and production of reports
• time and expertise required
Ask yourself: is your research project re-
alistic? Do you have the necessary re-
sources to be successful? If not, it may be
necessary to re-evaluate your plans.
Ensure that your research
resources are sufficient
You have already considered issues of ma-
terial, expertise, and time resources. In this
last task, it is essential to summarise the
issues and make final decisions. It is also
necessary to record the decisions in a writ-
ten evaluation plan that also summarises
other key elements of your planning pro-
cess.
With respect to data collection, analysis
and reporting, it is necessary to decide
upon:
• the personnel needed, including the use
of consultants, and the skills and ex-
pertise needed
Into action
As a last step, the team discussed their re-
search resources. With respect to data col-
lection, analysis and reporting they needed
the following resources:
1 Personnel needed
Planning the evaluations (Evaluation
team)
Sue R.: Psychiatrist
Adam S.: Scientific researcher
Chris C.: Drug Worker
Data collection
Programme secretary for entering intake
and termination records
Baseline interview for evaluating AIDS
education intervention
Conducted by clinical staff (drug
workers)
Follow-up interview
Conducted by clinical staff (drug
workers)
49Workbook 1  •  Planning Evaluations
WHO/MSD/MSB 00.2b
Supervision of interviews
Chris C.: Drug Worker
Data entry for outcome evaluation
Adam S., scientific researcher
Data analysis
Adam S.: scientific researcher
Supervision of implementing the outcome
evaluation
Sue R.: Psychiatrist
2 Salaries
Adam S. would be employed to assist
the evaluation.
3 Non-salary costs
Cost for printing questionnaires, fol-
low-up telephone interviews, editing
and printing reports
4 Time
In order to plan and implement both pro-
cess and outcome evaluation, a total of
18 months would be required.
Its your turn
1 Retrieve the following “It’s Your Turn”
exercises from this workbook:
Step 2
Step 3
Step 4 (A)
Step 4 (B)
Step 5
Step 6 (B)
Step 6 (F)
Step 7 (B)
Step 7 (C)
These exercises constitute the bulk of
the planning work you have completed
so far. Get all the exercises together,
and then review them step-by-step. Ask
yourself: do they create a reasonable,
well-organised plan?
2 Pay particular attention to the expected
time, costs, and expertise needed to
complete your evaluation. Are your re-
sources (Step 2) sufficient? If not, re-
turn to Step 4 and reformulate your
plans.
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Appendix 1
Depending on the activity being planned (for
example a TV commercial or a play), it will
be necessary to hold a number of focus
groups to obtain the desired information,
sometimes using the same group of partici-
pants to discuss other issues on the same
topic, and sometimes different groups of par-
ticipants to discuss different views on the
same topic.
Decide what you want
to know
Before convening a focus group, the
organisation (for example, the school, com-
munity centre, non-governmental
organisation, or health care facility) in as-
sociation with the facilitator, must deter-
mine the nature and extent of the informa-
tion that they require.
Lists should be prepared of the questions
and issues that need to be addressed. The
list will remind the facilitator during the
discussion of all the aspects that need to
be discussed.
At this point it is a good idea to consult
with a few people from the target popu-
lation you will be working with, whom
you already know. Show them your plan
and the list of questions, and ask them
whether they think the questions are rel-
evant and appropriate.
Focus group method
The focus group is a method for collecting
data on a specific group or population. It is
useful for:
• assessing a situation
• determining the needs and attitudes of
that population
• planning appropriate interventions and
responses. It is easy to organise and can
provide quick and relevant answers to
specific questions.
A focus group consists of a small group of
participants, preferably 6-10 people. It is
co-ordinated by a facilitator who can pro-
pose open-ended questions on a chosen
topic (like tobacco use, drug injection — see
some suggestions below in relation to PSU).
These discussions then can serve as the ba-
sis for developing a storyline on the specific
topic that is appropriate for the target group
(for example, adolescent PS users) or to de-
ciding on a health message.
The storyline should include some of the
problems and possible solutions raised by
the group. It can then be used for the pro-
duction of educational materials, using a
variety of techniques, as described in the
various sections of this guide.
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Identify the
participants
Participation in the focus group discussion
should be voluntary. One good way to get
a mixture of participants to attend a focus
group is to use a technique called “snow-
balling.” Ask two to three people whom
you already know to introduce you to some
of their friends. Then ask these new par-
ticipants to introduce you to other children
whom the first group does not know.
Depending on the objective of your ac-
tivity and the issues you will be discuss-
ing, there should be separate focus
groups for girls and boys.
The type of participant you select will de-
termine many other aspects of the focus
group. For example, the facilitator many
need to be more active and to reduce the
number of questions if the invited partici-
pants include people who regularly use PS.
In order to attract individuals to attend the
discussion, you could consider offering an
incentive. For example, you could provide
food during, or at the end of, the session.
This may, or may not, be a good idea, de-
pending on the group expectations and any
future activities you are planning.
The facilitator
The facilitator should have some training
and experience in group activities and also
be familiar with the problems related to
PSU, particularly with regards to the tar-
get group or community with whom he or
she is working. The facilitator must be fa-
miliar with the dialect or slang of the group.
It is also important that the members of the
focus group feel that the facilitator cares
about them and their problems. The main
tasks of the facilitator are:
• to create an atmosphere of safety
• to help the group focus its energy on the
task by suggesting methods and procedures
• to make sure all the members of the
group have an opportunity to partici-
pate
• to help participants present their ideas
to the group
• to protect members of the group from
personal attacks, put-downs, and criti-
cism
Depending on the activity you are plan-
ning and the characteristics of the group,
you may consider having two facilitators
if the group has eight or more participants.
Select a documenter
You need a documenter to record the dis-
cussion of the group. This person should
always:
• ask the permission of the group to
record the discussion, and any other in-
formation
• record the discussion accurately (writ-
ing and/or recording, photographing,
filming, etc.) and keep it confidential
• take care not to influence the record
with her or his own opinions
• be familiar with the dialects and slang
used by the group
• observe and record non-verbal infor-
mation about the group discussion (for
example, the emotional tone of the dis-
cussion, important hand gestures, un-
usual behaviour)
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Confirm attendance
and follow-up meetings
The facilitator should:
• keep in contact with the participants
until the time comes when he or she can
confirm their attendance
• select an appropriate meeting place,
date, time
• arrange all the materials necessary for
the discussion, including those specific
for the creative workshop
• inform the participants about the time
and place of any follow-up meetings
Conducting a focus
group discussion
The facilitator should:
• arrive at the location ahead of time,
check that everything is in order, includ-
ing tape recorders, batteries, etc., as re-
quired
• welcome the participants
• introduce himself/herself (and others
assisting) and explain what will be
happening, and who is recording the
proceedings (asking their permission
to do so)
• arrange an introductory activity to
help participants get to know each
other and relax before they start dis-
cussing the actual topic; it could be a
song, a prayer, or a brief game, in-
cluding an opportunity for people to
introduce themselves
• start the discussion by stating the general
purpose of the activity and the primary
topic of the focus group
• explain the procedure of the discussion
• ask the group for questions, sugges-
tions, and their expectations
• begin the discussion with a general,
open-ended question about the topic
Facilitate the dialogue
The facilitator must pay attention to the
process as well as the content of the
discussion. The process includes issues
such as:
1 who speaks and who does not,
2 what topics are avoided,
3 what issues upset the group,
4 whether the pace of the discussion is slow
or quick, and
5 how the participants interact with the fa-
cilitator.
The facilitator should also:
• encourage participants to share as much
information and as many insights as pos-
sible
• try to maintain an atmosphere in which
people take each other seriously, but
humour is still welcome, and help to
make it safe for people to share the feel-
ings behind their opinions
• show genuine interest in everything that
is said, and comment on special con-
tributions of members and on accom-
plishments of the group
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• deal politely with irrelevant information
• encourage the expression of different
viewpoints; the more important the de-
cision, the more important it is to have
all relevant facts, feelings, and opin-
ions
• take care not to judge responses nor
make long comments
• control over-talkative members and ask
for comments from quiet ones
• use different kinds of questions to in-
crease participation and interest; search
for all possible answers to a problem
by changing the perspective of the dis-
cussion
• keep the discussion focused on the sub-
ject
• summarise the discussion at frequent in-
tervals
• try to hold the participants attention by,
taking a break, stretching, switching
seats, saying something humorous, or
playing a brief game
• postpone a scheduled break if the group
is absorbed in its work
• defuse personal arguments between
members
• keep the emotional atmosphere of the
discussion at a level that can be toler-
ated by all the participants; if any of
the members becomes too distressed,
consider addressing his or her feelings
immediately, or letting the whole group
take a break
• as the discussion continues, check that
all the issues you listed have been prop-
erly covered
Conclude the focus
group discussion
Towards the end of the session, the facili-
tator should restate the objectives of the
discussion, and try to pull together the main
points made by the participants.
The facilitator should also:
• ask the participants whether the discus-
sion has missed any important issues
or questions
• express sincere appreciation for the
participants’ attention, time, and con-
tributions
• inform the participants of subsequent ac-
tivities, if any
• end the focus group discussion with a
feeling of togetherness — sing a song,
shake hands, or do a similar activity
that affirms the group and puts a sense
of closure to the time spent together
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Appendix 2
outcome monitoring being developed by the
Addiction Research Foundation, Ontario,
Canada. Information about these instruments
can be obtained from: Addiction Research
Foundation, 100 Collip Circle, Suite 200,
London, Ontario, Canada, N6G 4X8. These
measures are presented as examples only.
Reliability and validity data are not avail-
able. You must decide on their appropriate-
ness and availablility for your clients and
your culture. In addition to considering these
instruments, a review of the ARF Outcome
Measures Directory (undated) is highly rec-
ommended. This Directory contains many
potentially useful instruments for process
evaluation and discusses reliability, valid-
ity, and practical issues in administration.
In this appendix you will also find a sample
consent form, copies of the EuroQol EQ-
5D, the WHOQOL-BREF and scoring in-
struction as well as three examples of
questionnaires that can be used to assess
client satisfaction. Remember, it is up to
you to select the instrument(s) that are most
appropriate to your evaluation.
Sample questionnaires
The following pages contain a small sampling
of data collection instruments that can be used
in PSU evaluation, as well as the World Health
Organization’s ICD-10 diagnostic criteria for
substance use disorders.
The EuropASI is reprinted here with per-
mission of Dr. Anna Kokkevi of the Uni-
versity Mental Health Research Institute
(UHMRI), Athens, Greece. For more in-
formation about this instrument, see
Kokkevi, A. and Hartgers, C. (1995).
EuropASI: European adaptation of a mul-
tidimensional assessment for drug and al-
cohol dependence. European Addiction
Research, 1:208-210.
The AUDIT was developed by the World
Health Organization and is used widely to
assess alcohol use patterns.
The brief instruments measuring psychoac-
tive substance use, risk behaviour and health
and correctional service utilisation and cli-
ent motivation are adapted from a data col-
lection protocol for treatment process and
ICD-10 Diagnostic criteria for substance use disorders
The consumption of psychoactive sub-
stances can lead to a range of problems
that affect the health or social status of the
user. Many of these problems are defined
in the International Statistical Classifi-
cation of Diseases and Related Health
Problems, Tenth Revision (ICD-10).
ICD-10 disorders are not ranked in terms
of severity and are not mutually exclusive
from one another. In other words, a sub-
stance user may qualify for more than one
ICD-10 disorder, and Dependence is not
necessarily the most severe diagnosis.
Acute intoxication
Clear evidence of recent use of a psycho-
active substance at sufficiently high dose
levels to be consistent with intoxication.
Symptoms or signs of intoxication compat-
ible with the known actions of the particu-
lar substance and of sufficient severity
to produce disturbance in the level of
consciousness, cognition, perception,
affect, or behaviour that are of clinical
importance.
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Not accounted for by a medical disorder
unrelated to the substance use, and not bet-
ter accounted for by another mental or
behavioural disorder.
Harmful use
Clear evidence that substance use is re-
sponsible for (or substantially contributed
to) physical or psychological harm, includ-
ing impaired judgement or dysfunctional
behaviour, which may lead to disability
or have adverse consequences for inter-
personal relationships.
The nature of the harm is clearly identifi-
able.
The pattern of substance use has persisted
for at least 1 month or has occurred re-
peatedly within a 12-month period.
The disorder does not meet the criteria for
any other mental or behavioural disorder
related to the same substance in the same
time period (except for acute intoxication).
Dependence
At least 3 symptoms from the following:
• A strong desire or sense of compulsion
to take the substance.
• Impaired capacity to control substance-
taking behaviour in terms of onset, ter-
mination, or levels of use.
• A physiological withdrawal state when
substance use is reduced or ceased.
• Evidence of tolerance to the effects of
the substance.
• Preoccupation with substance use.
• Persistent substance use despite clear
evidence of harmful consequences.
• The pattern of substance use has per-
sisted for at least 1 month or has oc-
curred repeatedly within a 12-month pe-
riod.
• The symptoms have occurred within the
same period of time.
Psychoactive substance use
Substance
Used in past
12 months
(1= Yes / 2= No)
Number of days
used in past 90
(Days)
Average quantity
per day of use in
past 90 days*
Use currently a
problem?
(1= Yes / 2 = No)
* It may be difficult to quantify the exact amount for certain substances. Indirect estimates can be made from the number of times per day a substance is injected, inhaled, snorted, or smoked.
Alcohol (beer, liquor, wine)
Cocaine/ crack/ coke
Amphetamines/ other stimulants
Cannabis (hash, weed, grass, pot, marijuana)
Benzodiazepines
Barbiturates
Heroin/ opium
Prescription opioids
Over-the-counter codeine preparations
Hallucinogens
Glue/ other inhalants
Tobacco
Other psychoactive substances
56 Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2b
i) During the past 90 days, on how many days did you inject
any kind of psychoactive substance?
ii) Have you ever shared a needle, syringe, cooker/spoon or
cotton/filter with anyone at any time in your life?
If Yes, during the past 90 days, on how many days did you share
a needle, syringe, cooker/spoon or cotton/filter with anyone?
    During the past 90 days, with how many people have you
shared?
Risk behaviour
1 Thinking about your use of psychoactive substances, have you:
Never injected Injected prior to one year ago
Injected in the last 12 months Unknown
If ever injected, answer the following questions:
Health and correctional service utilisation
1 Thinking about physical health problems, during the past 90 days, how many:
•  times have you had to go to the emergency room times
•  nights total did you spend in the hospital nights
•  times did you have an outpatient surgical procedure times
•  times did you see a doctor in an office or outpatient clinic times
2 a) Thinking about mental health problems, during the past 90 days, how many:
•  times have you had to go to the emergency room times
•  nights total did you spend in the hospital nights
•  times did you see a doctor in an office or outpatient clinic times
days
days
people
2 How often do you use condoms with your sexual partner or partners?
Never Sometimes Always
During the past 90 days, how many times have you had
unprotected sex?
times
3 During the past 90 days, on how many days have you driven
a motor vehicle or used a machine at the workplace while
under the influence of alcohol or other psychoactive sub-
stances?
days
Yes No No response
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b)Are you currently in any type of treatment or counselling for mental or emotional
problems?
3 Over the last 90 days, how many days have you received alcohol or substance use
treatment at the following places?
• a hospital overnight for withdrawal or related problems days
• an inpatient substance use treatment facility (3 -90 days) days
• a long-term (3 to 12 months) residential program or
therapeutic community for substance use disorder treatment days
• a methadone or other opioid treatment program days
• an assessment or outpatient substance use treatment facility sessions
• a mental health centre or facility as an outpatient sessions
• an employee assistance program sessions
• a family and/or marital counselling service sessions
• an emergency room days
• a private doctor’s office visits
• a prison or jail days
• some other place (please describe __________________ ) days
Yes No No response
4 a) How many self-help meetings, (e.g., AA, NA, ACOA)
have you attended for your substance use problem in the past
90 days?
b) How many self-help meetings have you attended for issues
other than substance use problems in the past 90 days?
meetings
meetings
5 a) During the past 90 days, how many days have you been on probation or parole or
been in jail or custody?
• Probation days
• Parole days
• Jail/prison/closed custody days
• Open custody days
b) During the past 90 days, how many times have you been
charged for breaking the law (please do not count minor traf-
fic violations)?
times
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Were you charged with:
• driving while impaired
• drunkenness or other liquor law violation
• possession, distribution, or sale of illegal substances
• sexual assault
• theft (including B&E, theft over and theft under)
• violence against family or others
• major crime
• Other (please describe __________________________  )
Please
check if Yes
# of charges in
the last 90 days
Client Motivation
Treatment entry questionnaire:
Use the following scale to make your ratings
INSTRUCTIONS:
Please indicate
whether you
agree or disagree
with each of the
following
statements by
placing the
number that best
reflects your own
personal opinion
in the blank
provided.
Remember, there
are no right or
wrong answers,
and your
responses are
completely
confidential.
Strongly
Disagree
Strongly
Agree
1 If I remain in treatment it will probably be because I feel that
it’s the best way to help myself.
2 I plan to go through with a treatment program because I’ll hate
myself if I don’t get my habit under control.
3 I have agreed to follow a treatment program because I was
referred for treatment by the legal system.
4 I plan to go through with a treatment program because it’s a
challenge to learn how to live without misusing psychoactive
substances.
5 I plan to go through with a treatment program because my
friends and family won't approve of me unless I do.
6 Being in a program is a way for me to avoid getting punished
for my behaviours.
7 I decided to enter a program because I was interested in get-
ting help.
8 I decided to enter a program because I won't like myself very
much unless my substance use problem is under control.
9 I had no choice about coming into a treatment program.
10 I plan to go through with the treatment program because hav-
ing a substance use problem makes it hard for me to do things
I want to do.
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
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11 My family made sure that I entered a program.
12 If I remain in treatment it will probably be because others will
be angry with me if I don’t.
13 I decided to enter a program because I really want to make
some changes in my life.
14 I have agreed to follow a program because I want others to see
that I am really trying deal with my habit.
15 I plan to go through with treatment because I’ll be ashamed of
myself if I don’t.
16 I decided to enter this program because no one other than my-
self can change the way I am.
17 The reason I am in treatment is because other people have
pressured me into being here.
18 If I remain in treatment it will probably be because I’ll feel like
a failure if I don’t.
19 I plan to go through with a treatment program because I’ll get
into trouble with the law if I don’t remain in treatment.
20 I plan to go through with a treatment program because I have
freely chosen to be here.
21 If I remain in treatment it will probably be because people will
think I’m a weak person if I don’t.
22 I decided to enter a program because it feels important for me
personally to deal with my substance use problem.
23 I have agreed to follow a treatment program because I’ll get in trouble
with my friends and family if I don’t follow all the guidelines.
24 I plan to go through with a treatment program because not hav-
ing problems due to substances is a choice I really want to make.
25 My friends strongly pressured me to come into a program.
26 If I remain in treatment it will probably be because I’ll feel very
bad about myself if I don’t.
27 I have agreed to follow the procedures of the treatment program
because it’s a personal challenge for me to deal with my problem.
28 I have agreed to follow a treatment program because I was
pressured to come.
29 I decided to enter a program because people will like me better
when I have dealt with my habit.
30 I was basically forced into a treatment program.
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
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Sample Consent Form
PLEASE READ THIS CAREFULLY AND RETURN A SIGNED COPY TO YOUR COUNSELLOR. PLEASE
KEEP THE SECOND COPY FOR YOUR OWN RECORDS.
This form deals with your consent to take part in a follow-up study conducted by _______________________.
The purpose of this study is to help evaluate the services provided by the program.
IF YOU ARE 16 YEARS OF AGE OR YOUNGER you may also wish to have your parent(s) or guardian(s) read this
form and provide their written consent. If they have any questions regarding this study they should feel free to
contact the staff of programme at... telephone no... during regular business hours.
In consenting to participate in this study I understand:
1 I will be contacted by mail or telephone in about 6 months by a follow-up worker to arrange a personal
interview;
2 that at the interview I will be asked questions about my psychoactive substance use and other behaviours
during the last six months;
3 that in the event the follow-up worker is unable to reach me at the telephone number or address given
below, he/she may contact the following people to determine my whereabouts upon the condition the he/
she does not reveal any details about my participation in the study or why he/she wishes to contact me;
Name of contact person                                    Area Code & Telephone No. Relation
1.
2.
4 that the information given to the follow-up worker will be treated as confidential. It will not be shared
with my assessment worker, any persons at the program, or any other agencies;
5 I will not be identified in any reports and all published reports based on this study will only refer to
grouped data;
6 I reserve the right to decline the interview, or if I agree to the interview, I may refuse to answer specific
questions or terminate the interview at any time.
7 also understand that my participating in the study does not promise any therapeutic benefit. If I decline
to participate in the study or withdraw later, this will not affect the services I receive from the staff of the
program.
I, (signature), (date) hereby consent to take part in the follow-up study as outlined above.
Please print:
Name of Client Address
Name of Witness Date Signature
PARENT OR GUARDIAN:
My signature, (date) will serve to acknowledge my having read this form and agree that my child/ward may take
part in the follow-up study subject to the conditions described above.
Name of Witness Date Signature
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EXAMPLES 1-3: From Addiction Research Foundation
Examples 2 - 4 are
adapted from a data
collection protocol
for treatment process
and outcome
monitoring being
developed by the
Addiction Research
Foundation, Ontario,
Canada. Information
about the instruments
can be obtained from:
Addiction Research
Foundation, 100
Collip Circle, Suite
200, London, Ontario,
Canada, N6G 4X8.
There are no
reliability or validity
data of these
instruments. However,
they may be helpful to
stimulate ideas for the
development of a
questionnaire unique
to your needs. You
must decide on their
appropriateness and
availability for your
clients and your
culture.
In addition to
considering these
instruments, a review
of the ARF Outcome
Measures Directory
(undated) is highly
recommended. This
Directory contains
many potentially
useful instruments for
process evaluation and
discusses reliability,
validity, and practical
issues in
administration.
EXAMPLE 1
Please check the box at the end of each question that best reflects your
impression of detoxification:
1 The staff tried to understand my problems.
2 The information and advice that staff gave me
were helpful.
3 The staff helped me feel better physically while
drying out.
4 Information about me was kept confidential.
5 I was pleased with the way staff treated me.
6 During the day, I could see staff when I needed
to.
7 At night and on weekends, I was able to see
staff when I needed to.
8 The meals were satisfactory.
9 The detox was comfortable.
10 The detox was clean.
11 I felt safe in the detox.
12 The staff treated me with dignity and respect.
13 The staff were friendly and supportive.
14 There is enough space to be alone or to talk
privately with staff.
15 The type of help I was looking for was pro-
vided.
16 The staff handled it well when someone had
to be sent to hospital.
17 The staff handled it well when there fights or
trouble.
18 The staff made me feel welcome.
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EXAMPLE 2
Questions about whether client’s needs were met. Questions about whether client’s
needs were met  in a detoxification centre
1 What were your needs upon admission? Were these needs met?
2 Please check one or more answers to fill the space beside the question.
The most helpful information that I got was about:
my feelings
family or sexual problems
my substance use problem
housing
treatment choices
social agencies
counselling
health problems
none of the above
If Yes• food
• shelter
• personal safety
• support
• medical attention
• shower/bath
• other ___________________
No Yes No Partly Yes
If Yes
If Yes
If Yes
If Yes
If Yes
If Yes
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EXAMPLE 3
Rate the value of each of the following features of treatment using the following 4-
point scale:
Retrospective rating of usefulness of programme components
Helpful
Very
helpful
No
opinion
Not
helpful
1 Assessment
2 Therapist
3 The readings (two handouts)
4 Homework assignments
5 Problem-solving approach (identifying triggers and
consequences, evaluating options, using action plans)
6 Emphasis on doing it on my own (using my own
strengths and resources)
7 Self-selection of substance use goals
8 Availability of further treatment if desired
9 Follow-up contacts
10 Follow-up worker
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
We recognise that many things could have
happened to people over the two years of
follow-up that had nothing to do with the
treatment. The following questions largely
concern the effects that specific features
of the treatment had on you. Please an-
swer so as to describe the effects the treat-
ment had on you apart from other events
that may have happened in your life.
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EUROQOL EQ-5D
Scoring System
DEDUCTION
0.081 Constant deduction (for any dysfunctional state)
0.269 N3 (level 3 occurs within at least one dimension)
Mobility
0 1. No problems
0.069 2. Some problems walking about
0.314 3. Confined to bed
Self-care
0 1. No problems
0.104 2. Some problems walking or dressing self
0.214 3. Unable to wash or dress self
Usual activities
0 1. No problems
0.036 2. Some problems with performing usual activities
0.094 3. Unable to perform usual activities
Pain/discomfort
0 1. No pain or discomfort
0.123 2. Moderate pain or discomfort
0.386 3. Extreme pain or discomfort
Anxiety/depression
0 1. Not anxious or depressed
0.071 2. Moderately anxious or depressed
0.236 3. Extremely anxious or depressed
EuroQol scores are calculated by subtracting the relevant coefficients from 1.000. The
constant term is used if there is any dysfunction at all. The N3 term is used if there is
any dimension at level 3.
For example, consider the person who responds 1,1,2,2,3 to each of the dimensions,
respectively.
1.000 Full health
- 0.081 Constant term (for any dysfunction)
- 0 Mobility (level 1)
- 0 Self-care (level 1)
- 0.036 Usual activities (level 2)
- 0.123 Pain or discomfort (level 2)
- 0.236 Anxiety or depression (level 3)
- 0.269 N3 (level 3 within at least 1 dimension)
= 0.255 Total Quality Adjusted Life Year (QALY)
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WHOQOL-BREF
This manual was drafted by Alison Harper on
behalf of the WHOQOL group. The
WHOQOL group comprises a coordinating
group, collaborating investigators in each of
the field centres and a panel of consultants.
Dr J. Orley directs the project. He has been
assisted in this by Professor M. Power, Dr W.
Kuyken. Professor N. Sartorius, Dr M.
Bullinger and Dr A. Harper. The field centres
involved in initial piloting of the WHOQOL
were: Professor H. Herrman, Dr H. Schofield
and Ms B. Murphy. University of Melbourne,
Australia; Professor Z. Metelko, Professor S.
Szabo and Mrs M. Pibernik-Okanovic, Insti-
tute of Diabetes, Endocrinology and Metabolic
Diseases and Department of Psychology, Fac-
ulty of Philosophy, University of Zagreb,
Croatia; Dr N. Quemada and Dr A. Carla,
INSERM, Paris, France; Dr S. Rajkumar and
Mrs Shuba Kumar. Madras Medical College,
India; Dr S. Saxena and Dr K. Chandiramani,
All India Institute of Medical Sciences, New
Delhi, India; Dr M. Amir and Dr D. Bar-On,
Ben-Gurion University of the Negev,
BeerSheeva, Israel; Dr Miyako Tazaki, De-
partment of Science, Science University of
Tokyo, Japan and Dr Ariko Noji, Department
of Community Health Nursing, St Luke's Col-
lege of Nursing, Japan; Dr G. van Heck and
Mrs J. De Vries, Tilburg University, The Neth-
erlands; Professor J. Arroyo Sucre and Pro-
fessor L. Picard-Ami, University of Panama,
Panama; Professor M. Kabanov, Dr A.
Lomachenkov and Dr G. Burkovsky,
Bekhterev Psychoneurological Research In-
stitute. St. Petersburg, Russia; Dr R. Lucas
Carrasco, University of Barcelona. Spain; Dr
Yooth Bodharamik and Mr Kitikorn
Meesapya, I ltitute of Mental Health, Bangkok,
Introduction, administration, scoring
and generic version of the assessment
Thailand; Dr S. Skevington, University of
Bath, United Kingdom; Professor D. Patrick.
Ms M. Martinand, Ms D. Wild, University of
Washington, Seattle. USA and; Professor W.
Acuda and Dr J. Mutambirwa, University of
Zimbabwe, Harare. Zimbabwe.
New centres using the field version of the
WHOQOL-100 are: Dr S. Bonicato,
FUNDONAR, Fundacion Oncologica Argen-
tina, Argentina; Dr A.E. Molzahn, University
of Victoria, Canada; Dr G. Yongping, St
Vincent's Hospital, Victoria, Australia; Dr G.
Page. University of Quebec at Rimouski,
Canada; Professor J. Fang, Sun Yat-Sen Uni-
versity of Medical Sciences, People's Repub-
lic of China; Dr M. Fleck, University of the
State of Rio Grande do Sul, Brazil; Professor
M.C. Angermeyer, Dr R. Kilian,
Universitätsklinikum Klinik and Poliklinik fur
Psychiatrie. Leipzig. Germany; Mr L. Kwok-
fai, Queen Elizabeth Hospital. Kowloon, Hong
Kong; Dr B.R. Hanestad. University of
Bergen, Norway; Dr M.H. Mubbashar,
Rawalpindi General Hospital, Pakistan; Dr J.
Harangozo, Semelweis University of Medicine,
Budapest & Dr L. Kullman, National Institute
of Mental Rehabilitation, Budapest, Hungary;
Professor I. Wiklund. Health Economics &
Quality of Life, Astra Hassle AB. Sweden; Dr
C. Fidaner, Dr Behçet Uz Paediatric Hospital,
Balçova/lzmir, Turkey; Dr G. de Girolamo.
Servizio Salute Mentale USL 27, Italy; Pro-
fessor P. Bech, Frederiksborg General Hospi-
tal, Denmark; Dr R.S. Pippalla, Howard Uni-
versity, College of Pharmacy and
Pharmaceutical Sciences, Washington, DC,
USA and Dr H. Che Ismail, School of Medi-
cal Sciences, Kelantan, Malaysia.
Further information
can be obtained
from:
Dr John Orley
Programme on Mental
Health
World Health
Organization
CH-1211 Geneva 27,
Switzerland
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Introduction
The WHOQOL-100 quality of life assessment
was developed by the WHOQOL Group with
fifteen international field centres, simulta-
neously, in an attempt to develop a quality of
life assessment that would be applicable cross-
culturally. The development of the WHOQOL-
100, has been detailed elsewhere (i.e. Orley
& Kuyken, 1994; Szabo, 1996; WHOQOL
Group 1994a, 1994b, 1995). This document
gives a conceptual background to the
WHOQOL definition of quality of life and
describes the development of the WHOQOL-
BREF, an abbreviated version of the
WHOQOL-100. It also includes a generic En-
glish language version of the WHOQOL-
BREF, instructions for administering and scor-
ing, and proposed uses for this short form of
the WHOQOL.
Rationale for the
development of the
WHOQOL-100
WHO's initiative to develop a quality of life
assessment arose for a number of reasons. In
recent years there has been a broadening in
focus in the measurement of. health, beyond
traditional health indicators such as mortality
and morbidity (e.g. World Bank, 1993; WHO,
1991), to include measures of the impact of
disease and impairment on daily activities and
behaviour (e.g. Sickness Impact Profile;
Bergner, Bobbitt, Carter et al, 1981), perceived
health measures (e.g. Nottingham Health Pro-
file; Hunt, McKenna and McEwan, 1989) and
disability / functional status measures (e.g. the
MOS SF-36, Ware et al, 1993). These mea-
sures, whilst beginning to provide a measure
of the impact of disease, do not assess quality
of life per se, which has been aptly described
as "the missing measurement in health"
(Fallowfield, 1990). Second, most measures
of health status have been developed in North
America and the UK, and the translation of
these measures for use in other settings is time-
consuming, and unsatisfactory for a number
of reasons (Sartorius and Kuyken, 1994;
Kuyken, Orley, Hudelson and Sartorius, 1994).
Third, the increasingly mechanistic model of
medicine, concerned only with the eradica-
tion of disease and symptoms, reinforces the
need for the introduction of a humanistic ele-
ment into health care. By calling for quality of
life assessments in health care, attention is fo-
cused on this aspect of health, and resulting
interventions will pay increased attention to
this aspect of patients' well-being. WHO's ini-
tiative to develop a quality of life assessment
arises from a need for a genuinely interna-
tional measure of quality of life and a com-
mitment to the continued promotion of an ho-
listic approach to health and health care.
Steps in the
development of the
WHOQOL-100
The WHOQOL-100 development process
consisted of several stages. These are explained
in brief within this document. For a detailed
description, the reader is referred to the
WHOQOL Group (1994a, 1994b, in prepara-
tion). In the first stage, concept clarification
involved establishing an agreed upon defini-
tion of quality of life and an approach to in-
ternational quality of life assessment.
Quality of life is defined as individuals' per-
ceptions of their position in life in the context
of the culture and value systems in which they
live and in relation to their goals, expectations,
standards and concerns.
This definition reflects the view that quality
of life refers to a subjective evaluation which
is embedded in a cultural, social and environ-
mental context. Because this definition of qual-
ity of life focuses upon respondents' "per-
ceived" quality of life, it is not expected to
provide a means of measuring in any detailed
fashion symptoms, diseases or conditions, but
rather the effects of disease and health inter-
ventions on quality of life. As such, quality of
life cannot be equated simply with the terms
"health status", "life style", "life satisfaction",
"mental state" or "well-being". The recogni-
tion of the multi-dimensional nature of quality
of life is reflected in the WHOQOL-100 struc-
ture.
In the second stage of development, explora-
tion of the quality of life construct within 15
culturally diverse field centres was carried out
to establish a list of areas/facets that partici-
pating centres considered relevant to the as-
sessment of quality of life. This involved a
series in meetings of focus groups which in-
cluded health professionals, patients and well
subjects. A maximum of six specific items for
exploring each proposed facet were generated
by each centre's focus group. To enable the
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collaboration to be genuinely international the
15 field centres were selected world-wide to
provide differences in level of industrialisation,
available health services, and other markers
relevant to the measurement of quality of life
(e.g. role of the family, perception of time,
perception of self, dominant religion).
In the third stage of development, questions
from each centre were assembled into a glo-
bal pool. After clustering semantically equiva-
lent questions, 236 items covering 29 facets
were included in a final assessment. Pilot work
involved administration of this standardised
assessment to at least 300 respondents within
each centre.
Following field testing in these 15 centres, 100
items were selected for inclusion in the
WHOQOL-100 Field Trial Version. These in-
cluded four items for each of 24 facets of qual-
ity of life, and four items relating to the 'over-
all quality of life and general health' facet (see
Table 1). The method by which these 100
items were selected is fully documented else-
where (The WHOQOL Group, in prepara-
tion). The WHOQOL-100 Field Trial Version
is currently being tested in new centres world-
wide (these centres are outlined on page 6 of
this document). The initial conceptual frame-
work for the WHOQOL-100 proposed that
the 24 facets relating to quality of life should
be grouped into 6 domains. Recent analysis
of available data, using structural equation
modelling, has shown a four domain solution
to be more appropriate. For a more detailed
explanation of this, the reader is referred to
The WHOQOL Group (in preparation). The
WHOQOL-BREF is therefore based on a four
domain structure (see Table 1).
Table 1: WHOQOL-BREF domains
Domain Facets incorporated within domains
1   Physical health Activities of daily living
Dependence on medicinal substances and medical aids
Energy and fatigue
Mobility
Pain and discomfort
Sleep and rest
Work Capacity
2   Psychological Bodily image and appearance
Negative feelings
Positive feelings
Self-esteem
Spirituality / Religion / Personal beliefs
Thinking, learning, memory and concentration
3    Social relationships Personal relationships
Social support
Sexual activity
4    Environment Financial resources
Freedom, physical safety and security
Health and social care: accessibility and quality
Home environment
Opportunities for acquiring new information and skills
Participation in and opportunities for recreation /
leisure activities
Physical environment (pollution / noise / traffic / climate)
Transport
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Development of the
WHOQOL-BREF
The WHOQOL-100 allows detailed assess-
ment of each individual facet relating to qual-
ity of life. In certain instances however, the
WHOQOL-100 may be too lengthy for prac-
tical use. The WHOQOL-BREF Field Trial
Version has therefore been developed to pro-
vide a short form quality of life assessment
that looks at Domain level profiles, using data
from the pilot WHOQOL assessment and all
available data from the Field Trial Version of
the WHOQOL-100. Twenty field centres situ-
ated within eighteen countries have included
data for these purposes (see Table 2). The
WHOQOL-BREF contains a total of 26 ques-
tions. To provide a broad and comprehensive
assessment, one item from each of the 24 fac-
ets contained in the WHOQOL-100 has been
included. In addition, two items from the Over-
all quality of Life and General Health facet
have been included.
Table 2: Centres included in development of the WHOWL-BREF
Centres In the pilot version
of the WHOQOL
Centres In the field trial of
the WHOQOL-100
Bangkok, Thailand Bangkok, Thailand
Beer Sheva, Israel Beer Sheva, Israel
Madras, India Madras, India
Melbourne, Australia Melbourne, Australia
New Delhi, India New Delhi, India
Panama City, Panama Panama City, Panama
Seattle, USA Seattle, USA
Tilburg, The Netherlands Tilburg, The Netherlands
Zagreb, Croatia Zagreb, Croatia
Tokyo, Japan Tokyo, Japan
Harare, Zimbabwe Harare, Zimbabwe
Barcelona, Spain Barcelona, Spain
Bath, UK Bath, UK
St Petersburg, Russia Kowloon, Hong Kong
Paris, France Leipzig, Germany
Mannheim, Germany
La Plata, Argentina
Porto Alegre, Brazil
The WHOQOL-BREF is available in 19 dif-
ferent languages. The appropriate language
version, and permission for using it, can be
obtained from The WHOQOL Group,
Programme on Mental Health, World Health
Organisation, CH-1211 Geneva 27, Switzer-
land. Under no circumstances should the
WHOQOL-BREF be used without consulta-
tion with The WHOQOL Group. A method-
ology has been developed for new centres
wishing to develop a further language version
of the WHOQOL-100 or the WHOQOL-
BREF. This can be obtained from The
WHOQOL Group, Programme on Mental
Health, World Health Organisation, CH-1211,
Geneva 27, Switzerland.
Questions should appear in the order in which
they appear in the example WHOQOL-BREF
provided within this document, with instruc-
tions and headers unchanged. Questions are
grouped by response format. The equivalent
numbering of questions between the
WHOQOL-BREF and the WHOQOL-100 is
given in the example version of the
WHOQOL-BREF to enable easy comparison
between responses to items on the two ver-
sions. The WHOQOL-100 field test permit-
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ted centres to include national items or facets
that were thought to be important in assessing
quality of life. Where centres wish to include
additional national items or modules to the
WHOQOL-BREF, these should be included
on a separate sheet of paper and not scattered
amongst the existing 26 items. There are three
reasons for this:
1) To control for item order effects which
could occur and change item meaning.
2) The WHOQOL-BREF represents an
agreed upon core set of international items.
3) The WHOQOL-BREF is likely to be used
where quality of life is amongst one of sev-
eral parameters being assessed. Therefore
additional national information can be ob-
tained by including additional modules and
measures
Administration of the
WHOQOL-BREF
For any new centre not previously involved in
either the development or field testing of the
WHOQOL-100, the procedure being followed
to field test the WHOQOL-BREF should be
identical to that used to field test the
WHOQOL-100. The instrument should be
piloted on at least 300 people. This figure is
based on the required numbers of respondents
needed for analysis of pilot data. The sample
of respondents to whom the assessment should
be administered ought to be adults, with 'adult'
being culturally defined. While stratified
samples are not essential, a sampling quota
should apply with regard to:
• Age (50% = <45 years, 50% = 45 + years)
• Sex (50% = male, 50% = female)
• Health status (250 persons with disease or
impairment; 50 well persons)
With respect to persons with disease or im-
pairment, this group should contain a cross-
section of people with varied levels of quality
of life. One way of attempting this would be
to include some people with quite severe and
disabling chronic diseases, some people in con-
tact with health facilities for more transient
conditions, possibly some attending a family
practitioner, and others who are in contact with
the health service for reasons that are not likely
to impinge upon their quality of life to any
great extent. By sampling patients from a
cross-section of primary care settings, hospi-
tals and community care settings this could
most likely be achieved.
The WHOQOL-BREF should be self-admin-
istered if respondents have sufficient ability:
otherwise, interviewer-assisted or interview-
administered forms should be used.
Standardised instructions, given on the sec-
ond page of the WHOQOL-BREF example
assessment, should be read out to respondents
in instances where the assessment is inter-
viewer-administered.
For centres who have already participated in
the development and field testing of the
WHOQOL-100, the above option of testing
the WHOQOL-BREF is preferred, but not
imperative where specific studies of patient
groups are planned.
Frame of reference
and time frame
A time frame of two weeks is indicated in the
assessment. It is recognised that different time
frames may be necessary for particular uses
of the instrument in subsequent stages of work.
For example, in the assessment of quality of
life in chronic conditions, such as arthritis, a
longer time frame such as four weeks may be
preferable. Furthermore, the perception of time
is different within different cultural settings and
therefore changing the time scale may be ap-
propriate.
Proposed uses of the
WHOQOL-100 and the
WHOQOL-BREF
It is anticipated that the WHOQOL assess-
ments will be used in broad-ranging ways.
They will be of considerable use in clinical
trials, in establishing baseline scores in a range
of areas, and looking at changes in quality of
life over the course of interventions. It is ex-
pected that the WHOQOL assessments will
also be of value where disease prognosis is
likely to involve only partial recovery or re-
mission, and in which treatment may be more
palliative than curative.
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For epidemiological research, the WHOQOL
assessments will allow detailed quality of life
data to be gathered on a particular population,
facilitating the understanding of diseases, and
the development of treatment methods. The
international epidemiological studies that
would be enabled by instruments such as the
WHOQOL-100 and the WHOQOL-BREF will
make it possible to carry out multi-centre qual-
ity of life research, and to compare results
obtained in different centres. Such research
has important benefits, permitting questions
to be addressed which would not be possible
in single site studies (Sartorius and Helmchen,
1981). For example, a comparative study in
two or more countries on the relationship be-
tween health care delivery and quality of life
requires an assessment yielding cross-cultur-
ally comparable scores. Sometimes accumu-
lation of cases in quality of life studies, par-
ticularly when studying rare disorders, is helped
by gathering data in several settings. Multi-
centre collaborative studies can also provide
simultaneous multiple replications of a find-
ing, adding considerably to the confidence with
which findings can be accepted.
In clinical practice the WHOQOL assessments
will assist clinicians in making judgements
about the areas in which a patient is most af-
fected by disease, and in making treatment
decisions. In some developing countries, where
resources for health care may be limited, treat-
ments aimed at improving quality of life
through palliation, for example, can be both
effective and inexpensive (Olweny, 1992).
Together with other measures, the
WHOQOL-BREF will enable health profes-
sionals to assess changes in quality of life over
the course of treatment.
It is anticipated that in the future the
WHOQOL-100 and the WHOQOL-BREF will
prove useful in health policy research and will
make up an important aspect of the routine
auditing of health and social services. Because
the instrument was developed. cross-cultur-
ally, health care providers, administrators and
legislators in countries where no validated qual-
ity of life measures currently exist can be con-
fident that data yielded by work involving the
WHOQOL assessments will be genuinely sen-
sitive to their setting.
Scoring the WHOQOL-
BREF
The WHOQOL-BREF (Field Trial Version)
produces a quality of life profile. It is possible
to derive four domain scores. There are also
two items that are examined separately: ques-
tion 1 asks about an individual's overall per-
ception of quality of life and question 2 asks
about an individual's overall perception of their
health. The four domain scores denote an
individual's perception of quality of life in each
particular domain. Domain scores are scaled
in a positive direction (i.e. higher scores de-
note higher quality of life). The mean score of
items within each domain is used to calculate
the domain score. Mean scores are then mul-
tiplied by 4 in order to make domain scores
comparable with the scores used in the
WHOQOL-100. Explicit instructions for
checking and cleaning data, and for comput-
ing domain scores, are given in Table 3. A
method for the manual calculation of individual
scores is given on page 1 of the WHOQOL-
BREF assessment form. The method for con-
verting raw scores to transformed scores when
using this method is given in Table 4, on page
11 of these instructions. The first transforma-
tion method converts scores to range between
4-20, comparable with the WHOQOL-100.
The second transformation method converts
domain scores to a 0-100 scale.
Where more than 20% of data is missing from
a assessment, the assessment should be dis-
carded (see Step 4 in Table 3). Where an item
is missing, the mean of other items in the do-
main is substituted. Where more than two items
are missing from the domain, the domain score
should not be calculated (with the exception
of domain 3, where the domain should only
be calculated if < 1 item is missing).
Any national items should be scored separately
from the core 26 item of the BREF. During
the analysis the performance of any national
items will be examined for possible use in al-
ter national studies. At this stage of field test-
ing national and core items must not be mixed
in administration or scoring of the BREF.
An SPSS syntax file that automatically checks,
recodes data and computes domain scores may
be obtained from Professor Mick Power, De-
partment of Psychiatry, Royal Edinburgh Hos-
pital, Morningside Park, Edinburgh, EH10 5HF
(email: mj@srv2.med.ed.ac.uk; fax: + 131 447
6860)
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Table 3: Steps for checking and cleaning data and computing domain scores
Steps
SPSS syntax
for carrying out data checking, cleaning and
computing total scores
1 Check all 26
items from
assessment have
a range of 1-5
RECODE Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13
Q14 Q15 Q16 Q17 Q18 Q19 Q20 Q21 Q22 Q23 Q24 Q25 Q26
(1=1) (2=2) (3=3) (4=4) (5=5) (ELSE=SYSMIS).
(This recodes all data outwith the range 1-5 to system
missing).
2 Reverse 3
negatively
phrased items
RECODE Q3 Q4 Q26 (1=5) (2=4) (3=3) (4=2) (5=1).
(This transforms negatively framed questions to positively
framed questions)
3 Compute
domain scores
COMPUTE DOM1=MEAN.6(Q3,Q4,Q10,Q15,Q16,Q17,Q18)*4.
COMPUTE DOM2=MEAN.5(Q5,Q6,Q7,Q11,Q19,Q26)*4.
COMPUTE DOM3=MEAN.2(Q20,Q21,Q22)*4.
COMPUTE DOM4=MEAN.6(Q8,Q9,Q12,Q13,Q14,Q23,Q24,Q25)*4
(These equations calculate the domain scores. All scores are
multiplied by 4 so as to be directly comparable with scores derived
from the WHOQOL-100. The '.6 in 'mean.6' specifies that 6 items
must be endorsed for the domain score to be calculated).
4 Delete cases
with >20%
missing data
COUNT TOTAL=Q1 TO Q26 (1 THRU 5).
(This command creates a new column 'total'. 'Total' contains a
count of the WHOQOL-100 items with the values 1-5 that have
been endorsed by each subject. The 'Q1 TO Q26' means that
consecutive columns from 'Q1', the first item, to 'Q26', the last item,
are included in the count. It therefore assumes that data is entered
in the order given in the assessment).
FILTER OFF.
USE ALL.
SELECT IF (TOTAL>=21).
EXECUTE.
(This second command selects only those cases where 'total', the
total number of items completed, is greater or equal to 80%. It
deletes the remaining cases from the data set).
5 Check domain
scores
DESCRIPTIVES
VARIABLES=DOM1 DOM2 DOW DOW
/STATISTICS=MEAN STDDEV MIN MAX.
(Running descriptives should display values of all domain
scores within the range 4-20).
6 Save data set Save data set with a new file name so that the originalremains intact.
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Table 4: Method for converting raw scores to transformed scores
DOMAIN 1
Raw Transformed
score scores
4-20 0-100
7 4 0
8 5 6
9 5 6
10 6 13
11 6 13
12 7 19
13 7 19
14 8 25
15 9 31
16 9 31
17 10 38
18 10 38
19 11 44
20 11 44
21 12 50
22 13 56
23 13 56
24 14 63
25 14 63
26 15 69
27 15 69
28 16 75
29 17 81
30 17 81
31 18 88
32 18 88
33 19 94
34 19 94
35 20 100
DOMAIN 2
Raw Transformed
score scores
4-20 0-100
6 4 0
7 5 6
8 5 6
9 6 13
10 7 19
11 7 19
12 8 25
13 9 31
14 9 31
15 10 38
16 11 44
17 11 44
18 12 50
19 13 56
20 13 56
21 14 63
22 15 69
23 15 69
24 16 75
25 17 81
26 17 81
27 18 88
28 19 94
29 19 94
30 20 100
DOMAIN 3
Raw Transformed
score scores
4-20 0-100
3 4 0
4 5 6
5 7 19
6 8 25
7 9 31
8 11 44
9 12 50
10 13 56
11 15 69
12 16 75
13 17 81
14 19 94
15 20 100
DOMAIN 4
Raw Transformed
score scores
4-20 0-100
8 4 0
9 5 6
10 5 6
11 6 13
12 6 13
13 7 19
14 7 19
15 8 25
16 8 25
17 9 31
18 9 31
19 10 38
20 10 38
21 11 44
22 11 44
23 12 50
24 12 50
25 13 56
26 13 56
27 14 63
28 14 63
29 15 69
30 15 69
31 16 75
32 16 75
33 17 81
34 17 81
35 18 88
36 18 88
37 19 94
38 19 94
39 20 100
40 20 100
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Equations for computing domain scores
Domain 1 (6-Q3) + (6-Q4) + Q10 + Q15 + Q16 + Q17 + Q18
(6-Q3) + (6-Q4) + Q10 + Q15 + Q16 + Q17 + Q18
Domain 2 Q5 + Q6 + Q7 + Q11 + Q19 + (6-Q26)
Q5 + Q6 + Q7 + Q11 +   19 + (6-Q26)
Domain 3 Q20 + Q21 + Q22
Q20 + Q21 + Q22
Domain 4 Q8 + Q9 + Q12 + Q13 + Q14 + Q23 + Q24 + Q25
Q8 + Q9 + Q12 + Q13 + Q14 + Q23 + Q24 + Q25
WHOQOL-BREF
* Please see Table 4
on page 72 of the
manual, for
converting raw scores
to transformed
scores.
Transformed
scores*
Raw
score
4-20      0-100
=
=
=
=
ABOUT YOU
For office use only
I.D. number
Male Female
Before you begin we would like to ask you to answer a few general questions about
yourself: by circling the correct answer or by filling in the space provided.
What is your gender?
What is you date of birth?
     /          /             Day / Month / Year
What is the highest education you received?
          None at all              Primary school             Secondary school             Tertiary
What is your marital status?
          Single                 Separated                     Married
          Divorced                 Widowed                      Living as married
Are you currently ill?
         Yes                 No
If something is wrong with your health what do you think it is?
          illness     /                problem
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Please keep in mind your standards, hopes, pleasures and concerns. We ask that you
think about your life in the last two weeks. For example, thinking about the last two
weeks, a question might ask:
Moder-
ately
A great
deal
Not
much
Not
at all
1 2 3 4Do you get the kind of support from othersthat you need?
Com-
pletely
5
You should circle the number that best fits how much support you got from others over
the last two weeks. So you would circle the number 4 if you got a great deal of support
from others as follows.
Do you get the kind of support from oth-
ers that you need?
Moder-
ately
A great
deal
Not
much
Not
at all
1 2 3 4
Com-
pletely
5
You would circle number 1 if you did not get any of the support that you needed from
others in the last two weeks.
Please read each question, assess your feelings, and circle the number on the scale for
each question that gives the best answer for you.
1 (G1) How would you rate your qual-
ity of life?
Neither poor
nor good GoodPoor
Very
poor
1 2 3 4
Very
good
5
2 (G4) How satisfied are you with your
health?
The following questions ask about how much you have experienced certain things in
the last two weeks.
3 (F1.4) To what extent do you feel that
physical pain prevents you from
doing what you need to do?
4 (F11.3) How much do you need any
medical treatment to function in
your daily life?
5 (F4.1) How much do you enjoy life?
6 (F24.2) To what extent do you feel your
life to be meaningful?
A
moderate
amount
Very
muchA little
Not at
all
1 2 3 4
An
extreme
amount
5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
Neither
satisfied nor
dissatisfied
SatisfiedDissat-isfied
Very
dissatisfied
1 2 3 4
Very
satisfied
5
Instructions
This assessment
asks how you feel
about your quality
of life, health, or
other areas of your
life. Please answer
all the questions.
If you are unsure
about which
response to give to
a question, please
choose the one
that appears most
appropriate. This
can often be your
first response.
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The following questions ask about how completely you experience or were able to do
certain things in the last two weeks.
10 (F2.1) Do you have enough energy for
everyday life?
11 (F7.1) Are you able to accept your bodily
appearance?
12 (F18.1) Have you enough money to meet
your needs?
13 (F20.1) How available to you is the infor-
mation that you need in your day-
to-day life?
14  (F21.1)To what extent do you have the
opportunity for leisure activities?
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
7 (F5.3) How well are you able to con-
centrate?
8 (F16.1) How safe do you feel in your
daily life?
9 (F22.1) How healthy is your physical en-
vironment?
A
moderate
amount
Very
muchA little
Not at
all Extremely
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
Moder-
ately MostlyA little
Not at
all
Com-
pletely
1 2 3 4 5
1 2 3 4 5
Neither poor
nor good GoodPoor
Very
poor
1 2 3 4
Very
good
5
15  (F9.1) How well are you able to get
around?
The following questions ask you to say how good or satisfied you have felt about
various aspects of your life over the last
two weeks. Neither
satisfied nor
dissatisfied
SatisfiedDissatis-fied
Very
dissatisfied
1 2 3 4
Very
Satisfied
516  (F3.3) How satisfied are you with your
sleep?
17   (F10.3) How satisfied are you with
your ability to perform your daily
living activities?
18 (F12.4) How satisfied are you with your
capacity for work?
1 2 3 4 5
1 2 3 4 5
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19  (F6.3) How satisfied are you with
yourself?
20 (F13.3) How satisfied are you with
your personal relationships?
21 (F15.3) How satisfied are you with
your sex life?
22 (F14.4) How satisfied are you with the
support you get from your
friends?
23 (F17.3) How satisfied are you with the
conditions of your living place?
24 (F19.3) How satisfied are you with
your access to health services?
25 (F23.3) How satisfied are you with
your transport?
SatisfiedDissatis-fied
Very
dissatisfied
1 2 3 4
Very
Satisfied
5
1 2 3 4 5
1 2 3 4 5
Neither
satisfied nor
dissatisfied
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
The following question refers to how often you have felt or experienced certain things
in the last two weeks.
26  (F8.1) How often do you have nega-
tive feelings such as blue mood,
despair, anxiety, depression?
Did someone help you to fill out this form?
Quite
often
Very
oftenSeldomNever
1 2 3 4
Always
5
How long did it take to fill this form out?
Do you have any comments about the assessment?
THANK YOU FOR YOUR HELP
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Comments about
case examples
The two case examples in this workbook
are divergent, yet each demonstrates how
evaluation planning can (and should) be
tailored to address the unique needs of a
given situation.
The first case describes the evaluation plan-
ning process for a new mobile crisis inter-
vention and withdrawal management ser-
vice located in rural Northern Canada.
Evaluation was needed to determine the
exact nature of the services that were be-
ing provided, and to evaluate how well the
service was reaching its objectives. In this
case report, the author describes the steps
that evaluation members took to plan their
evaluation: assembling their team, creating
a programme logic model, outlining evalu-
ation questions, and choosing evaluation
measures and other data collection strate-
gies. The overall evaluation was large in
scope, encompassing all components of the
service and including follow up data.
However, the evaluators eased their re-
source burden somewhat by using infor-
mation from standard clinical forms as
much as possible. Other services with
fewer resources might choose to design
an evaluation that is narrower in scope.
Regardless, the same basic principles of
evaluation planning would still apply.
The second case describes the develop-
ment of a new data collection instrument:
the Maudsley Addiction Profile (MAP).
In this situation, the evaluators decided that
they needed an instrument that assessed a
wide range of substance use, yet was brief
to administer and simple to score. Once
developed, the MAP could be used for fu-
ture treatment evaluations. Similar steps
could be used by other evaluators inter-
ested in developing instruments specific
to their needs.
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Case example of
evaluation planning
The Timmins Home Detox Service
An Implementation Evaluation
by
Cindy Smythe
Evaluation Consultant
Addiction Research Foundation
Social Evaluation and Research Department
The Godron J. Mogenson Bldg.
100 Collip Circle, Suite 200
U.W.O. Research Park
London, Ontario N6G 4X8 CANADA
The author alone is
responsible for the
views expressed in
this case example.
Who was asking the
question(s) and why
did they want the
information?
The Timmins Home Detox Service
(THDS) is a mobile crisis intervention and
withdrawal management service located
in Timmins Ontario, Canada, a city in
Northern Ontario with a population of ap-
proximately 30,000 people. The service
was developed in response to the Addic-
tions Services Multi-Year Plan for the
Cochrane District Health Council. The
District Health Council had conducted a
need assessment that identified accessibil-
ity to district detoxification services by the
Timmins population as problematic. At the
time of the report, Timmins residents need-
ing detoxification services could only be
treated at the Cochrane District Detoxifi-
cation Centre in Smooth Rock Falls, a 110
kilometre trip. Not only was it less likely
that a client from Timmins would seek
treatment, but it was also expensive to
transport the client to and from the Detox
Centre.
The THDS provides assistance to people
in Timmins who are experiencing prob-
lems related to substance use. Through
mobile teams of trained professionals and
volunteers, the service offers crisis inter-
vention and supportive guidance, with-
drawal management, and advice related to
addiction issues to persons experiencing
problems, their families, and other sup-
porters, including employers. Depending
on client need, assistance is provided in
the client’s home, in hospital, at the
Cochrane District Detox Centre, and in
other safe places such as the home of a
volunteer or friend.
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The THDS was implemented by the
Cochrane District Detox Centre, but was
planned and developed with a community
coalition coordinated by the Timmins Cham-
ber of Commerce. Subcommittees prepare
and implement program design, recruit vol-
unteers, fundraise, and promote the service.
For a more detailed description of the model
this service used to guide its development,
please see A Guide for Planning With-
drawal Management Services in Rural
and Remote Areas and Small Urban Cen-
tres of Ontario (Addiction Research Foun-
dation, 1994).
The Addiction Research Foundation has
been a resource partner in the program de-
sign, and the integration of research and
planning for community development. The
director of the Cochrane District Detox
Centre who is also the director of the THDS
has worked closely throughout the project
and in all phases of the project with the
local Addiction Research Foundation
(ARF) program consultant and the chair
of the service’s planning coalition.
The evaluation had two major purposes.
First, the THDS was a new way of han-
dling withdrawal management in Ontario
and was serving as a model for other com-
munities who might wish to establish such
services. (At the time of the evaluation,
most detoxification in the province was
provided in one of 29 residential, non-
medical detoxification services funded by
the Ministry of Health.) Therefore, it was
necessary to monitor and document how
the THDS did its work in order to develop
information and training products for other
communities. Second was the interest of
the various stakeholders of the program in
knowing how well the service was doing
in achieving its objectives. Stakeholders
included the manager of the THDS, the
head of the volunteer association, the clini-
cal manager of the service, the volunteers,
the Addiction Research Foundation, the
community coalition, and the government
funder (the Ministry of Health). Since the
service was new and still evolving, we
planned to put the emphasis on process or
implementation evaluation rather than on
client outcomes.
In the province of Ontario, at the same time
as this new way of providing detoxifica-
tion services was being implemented, the
entire addictions treatment system was be-
ing rationalized. In other words, the Min-
istry of Health was looking for ways to
provide good or better service for clients
more efficiently. One of its guiding rec-
ommendations was that non-residential
detox be considered in any regional treat-
ment plan. Although there has been re-
search done in other countries such as Aus-
tralia, England, Scotland and the United
States (see, for example Stockwell et. al,
1991; Stinnet, 1982; Hayashida, 1989)
demonstrating the safety and effectiveness
of outpatient and home detox, home detox
in the Ontario setting had not been evalu-
ated. For that reason, the ministry was very
interested in the data and results of this
evaluation as it wanted some data to back
up its recommendation.
Component 1 - Service Awareness
One of the reasons for developing the
Timmins Withdrawal Management Service
was in response to the needs assessment
done in the community. The community had
identified the need for better access for
potential target groups than was being pro-
vided in the traditional residential social-
setting detox model. Four target popula-
tions in particular were identified as being
more likely to access an at-home service:
aboriginals, females, the elderly and
youth. It was also felt that certain groups
of referrers might increase their use of the
service if there were a home component
available to their clients. These were from
medical, mental health, law enforcement
and aboriginal services. Therefore, the
work in this component was to ensure that
any person or agency who may have need
of the Timmins Home Detox Service was
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aware of its existence and how to access the
service. This was attempted by providing
educational materials and presentations to
potential referrers. For the evaluation, we
wanted to know which kinds of awareness
materials worked best with which referrers.
For example, did the service need to de-
velop different materials to educate physi-
cians compared to educating other service
providers such as mental health workers?
Questions: What awareness materials
were developed? How were materials dis-
seminated? How satisfactory were mate-
rials for the intended audience of referrers?
How many clients were referred to each
detox option (residential or home) from the
targeted groups, i.e., aboriginals, females,
elderly, youth? How many referrals to each
detox option came from the targeted sec-
tors, i.e., medical, mental health, law en-
forcement, aboriginal services?
Component 2 - Assessment
The main work in this component was
assessing and identifying clients needing
either immediate crisis intervention or re-
ferral to withdrawal management ser-
vices and arranging transportation to the
least intrusive location consistent with
client needs. Every client who is deemed
appropriate and lives in the city of Timmins
was offered the non-traditional option,
that is, some form of home detox. For
the evaluation we wanted to know how
many people were being assessed, how
many were being referred to specialized
care, that is how many clients have par-
ticular medical or other needs that first
must be dealt with, how many were be-
ing referred to Home Detox, and how
many to the Detox Centre.
Questions: How many clients were being
assessed? What were the demographic
characteristics of clients being assessed?
How many clients were referred to (1) cri-
sis intervention, (2) withdrawal manage-
ment, (3) elsewhere? What were the criteria
that determined location of client referral?
Component 3 - Crisis Intervention
The work in this component was to inter-
vene with clients needing immediate ser-
vice because they were in crisis. (Nor-
mally clients who call when not in crisis
who wish to undergo withdrawal manage-
ment, decide on a date for the process to
begin.) The developers of this component
hoped that through the crisis intervention
service, clients who do not normally ac-
cess the addictions treatment system would
be introduced to it and would follow
through with withdrawal management post
crisis. However, they acknowledged that
some clients will only stay with the ser-
vice a short time — while they are in crisis,
usually about 24 hours. For those clients,
the THDS was able to provide crisis in-
tervention in the clients’ home community
thus saving the cost of transporting clients
110 kilometres for a short stay.
For the evaluation, we were interested in
who was accessing this service, that is,
what were the demographics of those cli-
ents, and whether clients who received
crisis intervention would otherwise have
accessed the system. We were also inter-
ested in whether clients were following
through on referrals to managing with-
drawal or other forms of continuing care.
Questions: If crisis intervention were not
offered, where would clients go for help?
Do clients who are referred to special-
ized assistance come back to the program
for withdrawal management? What are the
demographic characteristics of clients who
receive crisis intervention? What are the
demographic characteristics of clients who
stay in the program for withdrawal man-
agement following crisis? Are clients sat-
isfied with the service?
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Component 4 - Managing
Withdrawal
The work in this component was the ac-
tual withdrawal and stabilization of the
client. Trained staff monitored the client
in his or her home throughout the process
and arranged for medical services as
needed. It is important to note that clients
could come directly into the managing
withdrawal component following assess-
ment or could come into this component
following crisis intervention. At the first
visit to a client’s home, a Home Environ-
ment Assessment Form (Cooper, 1994)
was completed to be sure that home detox
was appropriate for the client and to de-
termine the amount of support available to
the client. The amount of support avail-
able by family or friends helps to determine
the number and frequency of contacts made
by the service. Clients also complete a Symp-
tom Severity Checklist (SSC) (Cooper,
1994) on the first visit and a shorter form
of the SSC each day. The Severity of Al-
cohol Dependence Questionnaire (SADQ)
(Stockwell, Murphy, and Hodgson, 1983)
was also completed by the client on the
second or third day depending on the
client’s physical and mental state. Results
from these scales were monitored by ser-
vice staff to determine whether the client
needed any medical intervention. The ser-
vice also provided clients and supporters
with a telephone number for immediate
contact with the service.
Questions:
1 The first set of questions we wanted to
ask were about the demographic dif-
ferences between clients who chose the
non-traditional or home option for
detoxification and those who preferred
the regular Detox Centre: What were
the demographic characteristics of cli-
ents in the different withdrawal program
options? Why did clients choose each
option?
2 The next set of questions were about the
withdrawal management process itself and
its effects on the client and family mem-
bers: What is the frequency, duration and
nature of in-person and telephone client
contacts by agency staff/volunteers? Is the
amount and nature of contact adequate?
Can a client who lives alone complete
withdrawal satisfactorily? What is the ef-
fect on family members of home with-
drawal management? What roles do fam-
ily members play? In which setting are
clients more likely to complete with-
drawal? Do clients who withdraw at home
miss the companionship of others found at
a detox centre?
Component 5 - Facilitating
Continuing Care
The work in this component was to ensure
that clients continue care following with-
drawal and stabilization. All clients in
both the Home Detox program and at the
Detox Centre are referred to one of the
two Addictions Assessment and Referral
Services in the district (for assessment and
referral to continuing care) and to mutual
aid (e.g., AA, NA) following withdrawal.
The detox program had made agreements
with the Addictions Assessment and Re-
ferral Services to the effect that the detox
would be given notification of whether
each client referred followed through on
the appointment to the service. Part of the
client consent form asked for permission
from the client to document this informa-
tion. Because of this relationship between
the detox service and the Assessment and
Referral services, we will be able to look
at this important outcome measure even
though the evaluation is essentially con-
cerned with implementation.
Questions: What are the characteristics
of clients who do and who do not continue
care? Does the type of detox experienced,
that is home or residential, make a differ-
ence in intention to continue treatment?
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Component 6 - Volunteers
Because volunteer recruitment, training, mo-
tivation and supervision were extremely im-
portant to this service, we decided to include
the component as part of this evaluation.
Trained volunteers work in pairs, under the
supervision of professional staff, to monitor
clients who are withdrawing in their homes.
We were particularly interested in finding out
how to meet the demand for service by us-
ing an appropriate mix of professionals and
volunteers. It is important that the volunteer
pool not be bigger than necessary because
administering the volunteer program takes
staff time that could be used for service
delivery.
Questions: How many volunteers per pro-
fessional staff are necessary to meet de-
mand? How many volunteers are neces-
sary in the pool vis à vis potential demand?
How long should a volunteers term be?
What skills should volunteers have?
What resources were
needed to collect and
interpret the
information?
Because this evaluation was seen as rather
large and complex, an evaluation consult-
ant from the Addiction Research Founda-
tion participated in all phases of the plan-
ning and implementation of the evaluation
and was responsible for the coordination
of all data collection. However, were the
service to undertake the evaluation itself,
it would not be necessary to undertake such
a large evaluation all at once. The evalua-
tion could be implemented in stages, look-
ing at specific questions over a period of
time. In that case, an evaluation consultant
may not be necessary or one could be used
sparingly over time.
For our evaluation, we relied on the fact that
the Detox Centre already collected client in-
formation that was stored in a database on
the service’s computer. The Centre was able
to provide statistics about service utilization
and client profiles. Therefore we planned that
the service itself would take the responsibil-
ity for collecting all the data necessary for
the evaluation. We planned that through its
normal record keeping computer database,
the service would generate most of the sta-
tistics for the evaluation report. For most of
the statistics we would gather, however, it
would not be absolutely necessary to use a
computer though a computer would make
the job easier. Many of the service utilization
statistics could be summarized by hand with
the help of a calculator.
How were the data
collected?
In order to begin the evaluation, we de-
veloped a Program Logic Model (see
Chart on next page). The first version of
the logic model for this program was de-
veloped by the director of the THDS in
collaboration with the program consultant
from the Timmins local office of the Ad-
diction Research Foundation. This model
was further developed and refined with
input from the program evaluator. All ver-
sions of the model were shared with mem-
bers of the community coalition. Once the
final version of the model was approved
by all the stakeholders, a similar proce-
dure was used to generate and refine the
evaluation questions. The questions were
generated following a full day meeting of
the detox director, the ARF program con-
sultant and the evaluator. The questions
were then shared with the coalition and
were also sent to the chair of the Ontario
Detox Directors Association for more
feedback. Attempts were made to incor-
porate all suggestions if appropriate.
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Working with a program logic model was
very useful in gaining consensus about the
workings of the service and how the ser-
vices provided were expected to have an
impact on clients. It should be noted that
most of the stakeholders had no real
knowledge about program evaluation.
They were unclear about the relationship
between objectives as stated in the logic
model and the eventual evaluation ques-
tions we had generated. For that reason,
time had to be scheduled at the feedback
meetings mentioned above for education
of the stakeholders. The evaluator prepared
teaching materials and led the group in a
simple logic model exercise so that ev-
eryone was familiar with the concepts.
The planned length of the evaluation was
twelve months. During that time we hoped
to monitor all clients who entered both the
Home Detox and the Detox Centre pro-
grams to document client demographics,
referrer demographics, services received,
and client satisfaction. We also planned to
evaluate the volunteer component of the
service.
Component 1 - Service Awareness
When we considered how we would col-
lect the information necessary to answer
our evaluation questions, we made every
effort to use as many of the normal record
keeping forms and materials that the ser-
vice was already using as we could. This
would make the data collection for the
evaluation less of a burden on the agency
whose main function is to provide service
to its clients.
In order to answer our questions about the
awareness materials, we decided records
should be kept of how the materials were
disseminated, that is, how were brochures
distributed, were information sessions
held, etc. A simple form was developed
to record this information. We then planned
to survey referrers to assess their satis-
faction with the materials and any presen-
tations they may have attended. Because the
THDS has a volunteer component, we
planned to have volunteers telephone
referrers following their receipt of the
materials. The volunteers would use a
short questionnaire we developed.
In order to answer our questions about ser-
vice utilization and referrals from targeted
referrers, we decided that normal record
keeping from client face sheets would be
used to record this information. In Ontario,
every government funded addictions treat-
ment agency is part of The Drug and Al-
cohol Treatment Information System
(DATIS). The face sheet form completed
for each client as part of DATIS contains
the name and profession/agency of the
referrer, the age, sex and ethnic background
of each client as well as other demographic
and substance use information. We planned
to compare client demographic data from
the DATIS face sheets to existing infor-
mation from the needs assessment to dis-
cover whether client profiles matched
those identified as needing better access
to detox services. We also would be able
to compare client and referrer demograph-
ics related to use of and referral to home
and residential detox.
All agencies and persons making referrals,
including self-referrals would also be
asked as part of the normal Intake Assess-
ment Form, completed for each client, how
they heard about the service and what they
would have done if the service were not
available.
Finally, we planned to survey referrers to
assess their satisfaction with the service
and their reasons for referring particular
clients to the service. Again, we planned
to use volunteers to either phone referrers
or to mail out a short questionnaire.
Quantitative and Qualitative Ap-
proaches: As always when collecting
data, it is important to consider the form
the information should be in, that is, do
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we want numbers (quantitative data) or do
we want words and description (qualita-
tive data)? We knew the information on
service utilization, in this case, would be
quantitative, that is, we were interested in
knowing the number of people in different
demographic categories who use the ser-
vice. We also wanted quantitative infor-
mation about the categories the referrers
represent. However, when we came to
evaluating the materials and satisfaction
with the service, we decided to use a mix-
ture of quantitative and qualitative ap-
proaches. Qualitative approaches would
be particularly useful during the process
of developing the promotional materials.
For example, we planned to distribute a
prototype of a brochure to a group of
people representing potential referrers
and hold a focus group in which people
would react to the brochure and suggest
improvements. This information would
then be used to redesign the brochure, if
necessary.
When assessing referrer satisfaction with
the service, a mix of both qualitative and
quantitative methods would be used. We
planned to develop some five-point scales
or a checklist on which referrers could
mark their satisfaction with aspects of the
service like ease of access, promptness of
service, etc. However, we also wanted to
ask some open-ended questions about
what referrers liked most and least about
the service.
In general, it is more time consuming to
collate and interpret qualitative data than
quantitative. Having access to a computer
or calculator and some basic computing
skills makes organizing and analysing quan-
titative data fairly efficient. On the other
hand, there is no fast way to organize quali-
tative data, but it can provide some very
rich information and is particularly useful
in the development phase of a product or
program.
Component 2 - Assessment
Again, we were able to use normal
record keeping forms to document most
of this information. We planned to use
one form for each client assessed con-
taining demographic information as de-
scribed in the first component (DATIS)
and location of the referral (Intake As-
sessment Form). Information about the
clients’ condition from the Intake Assess-
ment Form (that is, substances used and
last use, client’s level of intoxication,
any suicidal ideation, symptoms of with-
drawal, and withdrawal history) would
be compared to client referral informa-
tion to determine how decisions were
made when referring a client.
Component 3 - Crisis
Intervention
Again, we were able use normal record
keeping forms to document most of this in-
formation. There was one form for each
client assessed containing demographic in-
formation as described in the first compo-
nent (DATIS) as well as referral destina-
tion and whether clients referred to other
services recontacted the Home Detox fol-
lowing specialized treatment.
In order to determine client satisfaction
with the service, we decided to use the
eight-item version of the Client Satisfac-
tion Questionnaire (CSQ-8) (Larsen et al.,
1979) to be completed by clients before
they left the program. Information about
the CSQ-8 as well as information about
other client outcome measures can be
found in the Directory of client outcome
measures (Graham et al., 1993). Added
to that questionnaire would be a question
in which clients were asked what services
they would have used had they not been
aware of the THDS. Options they could
check off were: hospital, physician, jail/
police, on the street, stayed home, and
other.
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• To develop and
update profiles of
potential and actual
client population
• To develop
awareness materials
and educate sources
on the service and
how to access it.
• To negotiate
agreements and
protocols with
referal sources and
partner agencies,
especially mental
health and district
assessment and
referral agencies
• To provide crisis
intervention as
appropriate to
client’s immediate
needs
• To refer clients to
continuing care
consistent with care
plan goals.
Service
Awareness Assessment
Crisis
Intervention
Implementation
Objective
Short-term
Outcome
Objectives
• To provide
professional
assessment of clients
in person or by
telephone
• To refer clients as
appropriate to
- immediate special-
ised assistance (e.g.
medical)
-crisis intervention
or managing
withdrawal
• To arrange
transportation (if
necessary) to the
least intensive
location appropriate
to client’s needs.
• To increase overall
utilisation of the
service
• To increase referrals
from the following
populations:
aboriginals, females,
elderly, youth
• To increase referrals
from the following
referral sources:
medical, mental
health, law
enforcement, and
aboriginal services
• To increase clients
understanding of their
needs through
development of care
plans
• To increase
appropriate referrals
to care based on
clients’ needs
• To increase the
number of clients
receiving appropriate
crisis support
• To increase the
number of clients
who follow through
on  care plan goals
post crisis
• To increase access
for those clients who
do not normally enter
the addiction
treatment system
• To increase per person cost of withdrawal management services
• To increase access to withdrawal management services for traditional and
non-traditional clients
CHART: Programme Logic Model for
Long-term
Outcome
Objectives
Component
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• To provide or
arrange for a safe
withdrawal on a
positive non-
threatening place
• To provide trained
staff to monitor client
during withdrawal for
signs that alternate
care is required and/
or withdrawal is
completed.
• To arrange for an
access to emergency
medical services
should complication
arise.
• To arrange for
ongoing medical
management as
indicated in care plan.
Managing
Withdrawal
Faciliating
Continuing Care Volunteers
• To help make contact
with A/R and other
services and advise
professional care
providers regarding
relevant care issues
• To obtain
confirmation from
formal referral
destinations
regarding client entry
and completion
• To develop and
utilise materials for
recruitment of
volunteers
• To design and
implement a plan for
volunteer
development and
retention
• To design and
implement a training
programme for
service volunteers
• To increase the
number of clients
who complete
withdrawal
management
• To increase the
number of clients
who enter formal and
informal continuing
care
• To ensure numbers
and proportionals of
volunteers to
professionals are
necessary to meet
service demands
• To ensure an
adequate skill base
among volunteers
appropriate to client
needs.
• To improve continuity of care for clients requiring withdrawal management
services
• To increase the number of low-cost, innovative withdrawal management ser-
vices in Ontario
Timmis Withdrawal Management Service
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Component 4 - Managing
Withdrawal
Again, we were able to use normal record
keeping forms to document this informa-
tion as described in the above components.
In addition, clients were asked for infor-
mation about why they chose the with-
drawal management sites and options they
chose and if they thought their choices
were appropriate. If clients chose the non-
traditional option, we were interested in
whether they would have called if the
Detox Centre option were the only choice.
We added these additional questions to the
client satisfaction questionnaire described
below.
We were also able to use normal record
keeping forms to document all of the cli-
ent contact information, including number,
type and length of contacts. This was ac-
complished by using the Service Log
which is part of the DATIS system men-
tioned earlier, and used by all Ontario ad-
diction treatment programs. This Service
Log function allowed us to enter every
contact the client had either in person or
by telephone with the program staff. We
were also able to code what happened in
the contact, for example, ‘the client’s wife
wanted to discuss her concerns’. If such a
sophisticated system were not available,
the same information could be hand coded
and looked at for a sample of clients. Be-
cause of this system, we were able to track
frequency and duration of contacts for cli-
ents over the year of the study.
In order to assess client and family satis-
faction, we used adaptations of the forms
found in David Cooper’s book, Alcohol
Home Detoxification and Assessment
(1994). In order to use these forms we re-
ceived permission from the book’s pub-
lisher. To the satisfaction forms we added
questions about the roles family members
and/or friends played. We also asked cli-
ents if they missed the companionship of
others in a similar situation they would have
found in a Detox Centre.
Component 5 - Facilitating
Continuing Care
There are few addictions treatment pro-
grams in northern Ontario, consequently,
the managers of the services were very
collegial and already helped each other
track their clients. However, we wanted
to ensure that clients knew they were part
of a study; and so they were told about the
evaluation and were asked to complete the
client consent form giving us permission
for their records to be included. We as-
sured them that they would never be iden-
tified by name but only by an identifica-
tion number. We were then able to add the
information about whether or not clients
kept their appointments at the Addictions
Assessment and Referral Service. It was
beyond the scope of this evaluation to fol-
low up clients beyond the Assessment and
Referral Service to find out if they had then
gone to subsequent treatment.
Component 6 - Volunteers
As was mentioned above, we were able
to document the time spent by profession-
als and volunteers for each part of the ser-
vice through our DATIS Service Logs. This
quantitative information could then be
paired with qualitative information from
professional staff and volunteers about
their subjective experience and with cli-
ent and supporters’ satisfaction with the
service they received. We decided to in-
terview staff and volunteers to find out
their perceptions of their work load. From
this we hoped to be able to comment on
the appropriate mix of staff.
The question about the number of volun-
teers that should be available at any one
time was important because administer-
ing a large volunteer pool is time consum-
ing and takes away from other service. We
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decided we would monitor use of the volun-
teer pool to document demand over the year.
We were also interested in interviewing vol-
unteers to find out how they felt about ac-
tively working in the program as opposed to
being available but called infrequently.
How were the
data analysed?
The detox service director and the evalu-
ator decided that all data needed to evalu-
ate the program would be collected by the
service and input into the service’s data-
base in the usual manner by the service
support staff. Once the data were in the
service’s computer, the service would gen-
erate basic descriptive statistics as usual.
All analyses for the evaluation would be
descriptive in nature, that is, we would be
documenting the operation of the service
as described above. We planned to make
some comparisons between the clients in
the detox centre and those in the non-tra-
ditional environment using cross tabula-
tions. Clients would be monitored for one
year following the beginning of data col-
lection. Each component of the model
would be described separately.
All data would be linked by the client’s
unique DATIS identifier. Therefore, cli-
ent and family or supporter satisfaction
questionnaires would be precoded by the
detox service. In order to ensure client
confidentiality, detox workers would dis-
tribute the questionnaires with envelopes
and ask that the completed forms be sealed
in the envelopes before they are returned.
Only the support staff who enters the data
would see the questionnaires and that per-
son would not know the client or
supporter’s name.
At the end of the evaluation, we would be
able to describe the clients who enter both
detox services and crisis management; the
referrers and to which service they referred;
length of stay in the services and number and
duration of contacts in the home detox; sat-
isfaction with services; and number and de-
scription of clients who keep their appoint-
ments at the Assessment and Referral
services. We would also be able to comment
on the use of volunteers in the service.
Evaluation Plan
At this point we needed to develop a writ-
ten evaluation plan. The written plan was
important because in it we could set down
the various issues that had been discussed
in the course of this case study, for ex-
ample, what led up to the evaluation or
why was it being done; who the stakehold-
ers were; the program logic model; the
evaluation questions; what the organizing
principles were (that is, what key prin-
ciples and processes would guide the
evaluation? In our case we are trying to
make the process participatory and focus
the evaluation on process; how the results
would be reported and used; and finally,
costs.
We decided that the evaluator, in consul-
tation with the service’s director, the ARF
consultant and the chair of the community
coalition would write the plan. We would
discuss all components of the plan and the
final draft of the plan would be circulated
among the service’s staff and the members
of the coalition. This seemed to be a fair
division of work since the service was tak-
ing responsibility for all of the data entry
and generating the statistical reports. The
evaluator would also be responsible for
writing the final report of the evaluation.
Interim reports would be the responsibil-
ity of the service’s director and the ARF
program consultant in consultation with the
evaluator. The evaluation results would be
available to all of the stakeholders men-
tioned previously. We hoped that the detox
service staff would use the results to
modify and improve the program as neces-
sary. We assumed that the Ministry of Health
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would use any positive results to promote
the concept of home detoxification in the
province.
Costs
As was stated above, we planned to evalu-
ate the program for one year following the
beginning of data collection. Because the
detox director was so enthusiastic about
the evaluation, she volunteered her
service’s support staff to enter all of the
data collected into the computer as part of
her regular job. We also planned to use
the service’s volunteers to help collect
some data. Finally, we tried to use the
service’s usual data collection forms as
much as possible in the evaluation to lessen
the burden for the service’s workers who
must complete them. For these reasons, we
hoped to keep the cost of the evaluation
low. The services of the evaluator and the
Addiction Research Foundation program
consultant were provided at no cost to the
program. The ARF is funded by the same
branch of the government that funds ad-
diction treatment agencies and part of
ARF’s work is to support those agencies.
Of course, these costs, while not involving
exchanges of money, could be calculated out,
for example, the evaluator had dedicated
20% of her time to the project for the year,
the ARF program consultant, 30% of his
time, the service support staff, 15% of her
time, and so forth. The largest real money
outlays were travel expenses for the evalua-
tor to fly 800 kilometres to Timmins to meet
with the service’s staff and coalition. Some
of the travel costs were covered by the
fundraising efforts of the service’s volunteers
and coalition.
As was also stated earlier, it would not
be necessary for a service to undertake
a process evaluation of all components
of the service at once as was being
planned here. A service working alone
may decide to only evaluate one com-
ponent at a time and collect data for that
component for a shorter period of time
than we planned, for example for three
months. Over time all the components in
which the service was interested could
be evaluated and the costs and the re-
sources used would be less intense at
any one time.
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Its your turn
What are the strengths and the weaknesses of the presented case example? List three
positive aspect and three negative aspects:
Strengths of the case study
1
2
3
Weaknesses of the case study
1
2
3
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Case example of
implementing
evaluations
Development of the Maudsley
Addiction Profile (MAP)
Marsden J, Gossop M, Steward D, Best D, Farrell M, Edwards C, Lehmann P & Strang
J. (1998) The Maudsley Addiction Profile: A brief instrument for assessing treatment
outcome. Addiction 93, 1857-1868.
National Addiction Centre
Maudsley Hospital/Institute of Psychiatry
4, Windsor Walk, London, SE5 8AF, United Kingdom
Dr. John Marsden
National Addiction Centre,
Maudsley Hospital/Institute of Psychiatry
4, Windsor Walk, London, SE5 8AF, UK.
Tel: + + 171 919 3830
E-mail: J.Marsden@iop.kcl.ac.uk
Who was asking the
question(s) and why
did they want the
information?
This case study summarises the development
of the Maudsley Addiction Profile (MAP).
The MAP is a brief, interviewer-adminis-
tered questionnaire for use with problem
drug users (DUs) and alcohol users (AUs).
It has been developed by a team of re-
searchers in association with clinical staff
at the Maudsley Hospital/Institute of Psy-
chiatry, London. The MAP is intended for
use in treatment outcome research and for
The authors alone
are responsible for
the views expressed
in this case example.
routine use by treatment programmes for
evaluation. The items have been selected
to be sensitive to change and the instru-
ment can be administered at one or more
points during and after treatment.
In our development studies we wanted the
MAP to have: (i) good content and face
validity; (ii) brief administration; (iii) simple
scoring with clear and unambiguous inter-
pretation; and (iv) acceptable standards of
test-retest reliability. The first stage in-
volved a review of the relevant literature
and discussions with key informants in the
research and clinical fields in the UK and
internationally about the relevant assess-
ment domains for this client population
94 Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2b
(Marsden, 1994). Four domains emerged as
essential components of an outcome ques-
tionnaire: (a) drug and alcohol consumption;
(b) health risk behaviour; (c) health prob-
lems; and (c) personal/social functioning (the
latter usually spanning relationship problems,
employment and crime involvement)
(McLellan et al. 1980; Babor et al. 1994;
Simpson & Chatham 1995). For the first
domain, it is important to note that we elected
to assess the typical quantity of substance
use. Whilst we acknowledge the accuracy
of self-reports of drug doses is problematic,
we considered that this is a desirable clinical
and research measure.
The development of measures in each of these
four domains was guided by existing concise
omnibus instruments for treatment outcome
evaluation — the Addiction Severity Index
(ASI, McLellan et al. 1980; McLellan et al.
1992a) and the Opiate Treatment Index
(OTI, Darke et al. 1992). We were also in-
formed by our work on developing measures
and working with treatment providers dur-
ing the planning phases for the UK’s National
Treatment Outcome Research Study (see
Gossop, Marsden & Stewart, 1998, for de-
scription). On the basis of this review phase,
we established for following structure for the
MAP.
Structure of the Maudsley Addiction Profile (MAP)
Substance use Consumption • Days used
• Usual amount taken on using day
• Usual route (oral, intranasal, inhalation,
injection)
Domain Measure Variable (behaviour in past 30 days)
Risk behaviour Injecting • Days injected and times injected per day
• Times shared needle/syringes
Sexual • Number of sexual partners (non-condom)
• Times had sex when not using a condom
Health Physical • Frequency of major symptoms (general,
gastrointestinal, neurological, musculo-
skeletal, cardio-respiratory)
Psychological • Frequency of major symptoms (anxiety
and depression)
Social
functioning
Employment • Days in paid work/unemployment
• Work days lost due to absence
Crime • Days committed drug selling
• Days committed shoplifting and other of-
fences
Relationships • Days contact with partner/relatives/friends
• Days conflict with partner/relatives/friends
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The MAP comprises an introductory sec-
tion and, in the version used for field testing,
contains a total of 60 items. A recall period
of the past 30 days before intake to treat-
ment is used. Given the purpose of the in-
strument, no lifetime or history measures are
included. The purpose and structure of the
MAP and confidentiality issues are explained
to the client at the start of the interview and
their age, gender, and ethnic group recorded.
Substance use
The first section has 22 items. In the field
test version, the following substances were
recorded: illicit heroin, prescribed and
non-prescribed methadone, prescribed and
non-prescribed benzodiazepines (com-
monly diazepam and temazepam), cocaine
base (crack), cocaine hydrochloride and
alcohol. To assist recall, the client is shown
a response card which lists seven com-
mon frequency patterns (ranging from one
day per week to every day). In this way,
the total number of days in the month be-
fore intake when use of each substance took
place is recorded first. The intensity (or
quantity) of use is then recorded from the
client’s verbatim report of the amount con-
sumed on a typical using day in the past
month. In instances where the quantity has
varied, the client is asked to recall the
amount used on the two-three most recent
days in the recall period when use took
place. The amount used is recorded for
each of these days and later averaged. With
the exception of alcohol, the usual route(s)
of substance administration during the re-
call period is also recorded, using the fol-
lowing categories: oral, intra-nasal, inha-
lation and injection.
Injecting and sexual risk
behaviour
The second domain has five measures. The
number of days on which the client injected
is recorded together with the number of
injections on a typical day. If injecting has
been episodic, it is recorded using the same
procedure for the frequency of episodic sub-
stance use. The client is also asked about
the number of times they have injected using
a needle/syringe which they believe has al-
ready been used by someone else (our defi-
nition of needle/syringe sharing). As a proxy
of recent sexual risk behaviour, the client is
asked to estimate the number of people and
the total number of times that they have had
penetrative sexual intercourse without using
a condom.
Physical and
psychological health
The third domain has 20 items. For physi-
cal health, a 10-item symptom scale was
adapted from the 51-item checklist devel-
oped by Darke and colleagues for the Opi-
ate Treatment Index (Darke et al. 1991).
A five-point Likert-type scale was in-
cluded to assess the frequency of experi-
encing each symptom (never, rarely, some-
times, often, always (scored 0-4) in order
to maximise change sensitivity. The scale
is simply scored by summing the values
across each item (range 0-40). A 10-item
scale to assess general emotional prob-
lems was derived and adapted from the
six-item anxiety and depression sub-scales
of the Brief Symptom Inventory (BSI,
Derogatis 1975). The scale is simply
scored by summing the values across each
item (range 0-40). Separate scores for anxi-
ety and depressive ideation may also be
computed.
Social functioning
The fourth domain has nine items in three
sub-sections:
(i) Relationship conflict. A measure of se-
rious conflict experienced by the client is
taken by recording the number of days on
which the client had contact with his/her
usual sexual partner, relative(s) and
friends, and the number of days on which
there was serious conflict between the cli-
ent and each one or group. These measures
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were based on the measurement of family
conflict developed for the Addiction Se-
verity Index (McLellan et al. 1992a). If
the client was not in a personal relation-
ship, or did not have any relatives or
friends, a score of zero is recorded. These
measures are subsequently expressed as a
percentage of conflict to contact days.
(ii) Employment. Three measures of em-
ployment are taken: the number of days of
formal unemployment; the number of days
on which the client undertook paid work; and
the number of working days on which the
client did not attend work due to sickness or
unauthorised absence.
(iii) Criminal behaviour. In this final sec-
tion, the three categories of criminal ac-
tivity are recorded: sales of illegal drugs,
shoplifting, and other crime. The latter cat-
egory groups the following offences to-
gether: theft from a property, theft from a
person, theft from or of a vehicle, and
fraud/forgery. The client is asked to recall
the frequency of days on which the crime
type was committed during the past month.
Finally, as a measure of intensity of crime
involvement, the respondent is asked to es-
timate the number of times each crime type
has been committed on a typical day.
What resources were
needed to collect and
interpret the
information?
Internal research and clinical resources
were used for the development of the MAP
questionnaire and its initial psychometric
evaluation. The research team, led by the
first author, comprised two male and two
female researchers. All were experienced
members of the Addiction Research Unit
and trained to first, masters or doctoral
degree level in psychology or sociology. Two
male and two female clinical nurses partici-
pated as interviewers under the supervision
of the fifth author (a consultant psychiatrist).
All were experienced members of our clini-
cal services and were trained in general or
psychiatric nursing with addictions special-
ties. Our internal research and clinical re-
sources were supplemented with a research
grant from the English Department of Health
in support of the project. In support of the
project, we prepared a detailed protocol and
instruction set and used a single two hour
training session to induct the interviewers into
the conduct of the interviews. Periodic meet-
ings were held during the course of field testing
to discuss and resolve any difficulties encoun-
tered in interviewing clients.
How were the
data collected?
We conducted field testing studies with
samples of DUs and AUs at our commu-
nity and in-patient services at the Maudsley
Hospital, London. For a detailed descrip-
tion of the initial psychometric evaluation
of the instrument see Marsden et al (sub-
mitted for publication). Two multi-disci-
plinary community programmes partici-
pated: an opioid substitution and
detoxification service for drug users and
an assessment, brief intervention, and
detoxification service for AUs. Two in-
patient programmes also participated: a
30-day detoxification and relapse preven-
tion service for DUs and a 10-day assess-
ment and detoxification service. The pur-
pose of these studies was to evaluate several
aspects of the psychometric performance of
the MAP. A quota-recruitment procedure
was used to obtain a total of 240 clients (160
men and 80 women) from the four treatment
programmes for the test-retest and concur-
rent validation assessments. The eight inter-
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viewers each interviewed 30 clients (20 DUs
and 10 AUs). Participation in field testing was
voluntary and no client was paid for their time.
How were the
data analysed?
Psychometric evaluations of test-retest were
assessed using the intra-class correlation
coefficient (ICC) for interval measures and
Cohen’s Kappa for categorical measures.
What did they find out?
The items in the MAP were found to be highly
acceptable to a majority of the clients. The
average completion time for the test inter-
view was 11.7 minutes ( range = 6-27 min-
utes). Satisfactory results were obtained from
the assessment of self-report with urine test-
ing, concurrent validity of scales with com-
parable measures and 3-day intra-inter-
viewer test-retest reliability.
How were the
results used?
The results of the initial field testing of
the MAP achieved satisfactory perfor-
mance in terms of the development objec-
tives we set for the instrument and the de-
sign and field testing phases of the study
provided evidence to satisfy each of these.
These results have several implications for
outcome research in practice. In practice,
the eight substances recorded in the field-
tested version of the MAP will need to be
expanded to include other substances as
prevalent patterns of use change over time
and location. Alternative recall periods
could also be used: either the past 60 days
(two months); the past 90 days (three
months) or even the past 180 days (six
months).
If the MAP is used widely as part of routine
clinician practice, there are advantages in in-
corporating it within existing clinical assess-
ment records and procedures. This is the
approach we have taken in our own services.
We recommend that a modular approach to
outcome research is adopted in which a pri-
mary set of outcome measures are recorded,
with other outcome measures included as
required. Measures of treatment itself are also
clearly needed and there are several instru-
ments available which record different aspects
of treatment processes and programme en-
vironment (Simpson & Chatham 1995; Moos
1988b; McLellan et al. 1992b). As a mini-
mum, the setting, modality and duration of
treatment should be recorded. Additional
measures of the client’s choice of treat-
ment goals, the amount of programme ser-
vices received, their treatment discharge
status and additional non-index treatments
received, could also be used in a more
comprehensive outcome evaluation. We
have also recently developed the Treat-
ment Perceptions Questionnaire (TPQ), a
brief 10-item measure of addiction treat-
ment satisfaction, which can be used as an
adjunct to quantitative outcome assess-
ments (Marsden et al., in press).
We conclude that the MAP development
study has demonstrated that collection of
a set of quantitative measures of problems
experienced by clients should not place a
significant administrative burden on treat-
ment or research personnel. In conse-
quence, we hope that it may stimulate the
development of research activity by treat-
ment providers.
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Its your turn
What are the strengths and the weaknesses of the presented case example? List three
positive aspect and three negative aspects:
Strengths of the case study
1
2
3
Weaknesses of the case study
1
2
3
